By The Editors
Healio: “The FDA has granted priority review to Farxiga, from AstraZeneca, for the treatment of chronic kidney disease. If approved, it would be the first SGLT2 inhibitor on the market to treat this patient population, according to a press release…” Click here for full story.
Science Daily: “All prediabetes is not the same: in people in the preliminary stages of type 2 diabetes, there are six clearly distinguishable subtypes, which differ in the development of the disease, diabetes risk, and the development of secondary diseases…” Click here for full story.
Medscape: “Among people with type 1 diabetes (T1D) who contract COVID-19, Black individuals are four times more likely than Whites to be hospitalized with diabetic ketoacidosis (DKA), new data suggest…” Click here for full story.
Healio: “In this issue, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with the director of practice and content development at the Association of Diabetes Care & Education Specialists, Joanne Rinker, MS, RDN, CDCES, LDN, FADCES, about the need to identify and manage hearing loss in diabetes care…” Click here for full story.
Healio: “Individuals with type 1 diabetes had lower mean glucose levels and spent more time in range on days they exercised compared with sedentary days, according to data published in Diabetes Technology & Therapeutics…” Click here for full story.
Healio: “Fatal outcomes in COVID-19 were associated with patients with CVD and risk factors such as hypertension and diabetes across all age groups, according to a meta-analysis…” Click here for full story.
Medscape: “The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid…” Click here for full story.
Yahoo: “In recent years… scientists have been questioning whether the role of dietary fat may be more nuanced than previously believed. That’s why researchers from the German Center for Diabetes Research set out to investigate the relationship between diabetes and various kinds of dietary fat…” Click here for full story.
Healio: “Individuals with type 1 diabetes and those with type 2 diabetes have similar increased risks for COVID-19 hospitalization and severe illness compared with those without diabetes, according to a study published in Diabetes Care…” Click here for full story.
U.S. News & World Report: “Back in August, the U.S. Centers for Disease Control and Prevention analyzed more than 10,000 COVID-related deaths between February and May. The study found that almost 40% of the people who died had diabetes. A study by Reuters found similar results. This past November, another study conducted in England homed in on one specific complication of diabetes, called diabetic retinopathy…” Click here for full story.
Medscape: “For 2021, the American Diabetes Association (ADA) offers new guidance on assessing patients’ financial and social barriers to care, especially given the COVID-19 pandemic, individualizing treatment of patients with type 2 diabetes, and use of diabetes technology…” Click here for full story.
World Economic Forum: “It’s the silent epidemic that claims 4.2 million lives around the world every year – almost three times as many deaths as COVID-19. Diabetes is on the march, with experts predicting that one in 10 of us will be affected by 2045…” Click here for full story.
Healio: “JDRF has launched the first mass screening program for early detection of type 1 diabetes called T1Detect, part of a larger effort to prevent disease complications like diabetic ketoacidosis and speed the pace of research for a cure…” Click here for full story.
Science Daily: “In a new study, researchers from Tokyo Medical and Dental University (TMDU) discovered that infection with Porphyromonas gingivalis, the bacterium causing periodontal disease, causes skeletal muscle metabolic dysfunction, the precursor to metabolic syndrome, by altering the composition of the gut microbiome…” Click here for full story.
Healio: “Postmenopausal women with type 2 diabetes have increased bone mineral content and lower bone turnover markers vs. those with normal or impaired glucose tolerance, according to data published in the Journal of Bone and Mineral Research…” Click here for full story.
Medscape: “Individuals experiencing a current episode of major depressive disorder (MDD) are significantly more likely to have insulin resistance (IR), new research shows…” Click here for full story.
Science Daily: “Researchers have discovered individuals with type 1 and type 2 diabetes infected with COVID-19 are three times more likely to have a severe illness or require hospitalization compared with people without diabetes…” Click here for full story.
Healio: “Proper glucose management can help improve outcomes for individuals with diabetes who are infected with COVID-19, and providers should not deviate from current diabetes treatment, according to a speaker…” Click here for full story.
CIDRAP: “A Lancet Healthy Longevity study yesterday found that metformin — a common, generic type 2 diabetes medication used to manage blood sugar levels — is associated with significantly lower COVID-19 death risk in women, but not in men…” Click here for full story.
Medscape: “Risk of intubation for COVID-19 in very sick hospitalized patients was increased over fivefold in those with diabetic retinopathy compared to those without, in a small single-center study from the UK…” Click here for full story.
Healio: “Adults with COVID-19 admitted to two ICUs in China were at greater risk for secondary respiratory infections, acute respiratory distress syndrome and mortality with an HbA1c of 6.5% or higher, according to study data…” Click here for full story.
Science Daily: “University of California San Diego School of Medicine researchers found evidence that triclosan — an antimicrobial found in many soaps and other household items — worsens fatty liver disease in mice fed a high-fat diet…” Click here for full story.
Medscape: “Older adults should be recommended for hospital-based lifestyle interventions to reduce weight, say UK investigators after finding there was no difference in weight loss between older and younger individuals in their program for those with morbid obesity…” Click here for full story.
U.S. News & World Report: “COVID-19 patients with high blood pressure or diabetes may be more likely to develop critical neurological complications, including bleeding in the brain and stroke, according to an ongoing study…” Click here for full story.
Healio: “Severe hypoglycemic episodes are a marker of, rather than causally related to, an increased risk for death among adults with type 2 diabetes, according to data published in Diabetologia…” Click here for full story.
Science Daily: “Short bursts of physical exercise induce changes in the body’s levels of metabolites that correlate to, and may help gauge, an individual’s cardiometabolic, cardiovascular and long-term health, a study has found…” Click here for full story.
Medscape: “The human monoclonal antibody golimumab (Simponi) preserved endogenous insulin secretion in patients with new-onset type 1 diabetes and reduced their exogenous insulin requirements at 1 year, newly published phase 2 data indicate…” Click here for full story.
Medscape: “Women with type 2 diabetes who take metformin during pregnancy to control their blood glucose levels experience a range of benefits, including reduced weight gain, reduced insulin doses, and fewer large for gestational age babies, suggest the results of a randomized controlled trial…” Click here for full story.
Medscape: “A novel randomized trial taking on a vexing issue around one of the world’s most commonly prescribed medications has concluded that frequently intolerable statin side effects, such as muscle weakness or pain, are almost entirely a nocebo effect, the placebo effect’s darker cousin…” Click here for full story.
Science Daily: “Scrambled, poached or boiled, eggs are a popular breakfast food the world over. Yet the health benefits of the humble egg might not be all they’re cracked up to be as new research shows that excess egg consumption can increase your risk of diabetes…” Click here for full story.
Healio: “A cohort of women with gestational diabetes received more comprehensive information on nocturnal hyperglycemia with use of a continuous glucose monitor than through self-monitoring blood glucose, according to study data…” Click here for full story.
Science Daily: “A new UC Riverside study shows flame retardants found in nearly every American home cause mice to give birth to offspring that become diabetic…” Click here for full story.
Healio: “Data show Black adults with type 2 diabetes and moderate chronic kidney disease were significantly less likely to receive a metformin prescription compared with white counterparts under an old FDA serum creatinine-based metformin label…” Click here for full story.
Medical Dialogues: “Daily physical activity (PA) is associated with blood sugar levels after an evening meal in diabetes patients, suggests a recent study in the journal Diabetes Technology & Therapeutics. The results indicate that quantitative assessment of physical activity could be relevant for mealtime treatment decisions…” Click here for full story.
Science Daily: “Time-restricted eating, which restricts eating to specific hours of the day, did not impact weight among overweight adults with prediabetes or diabetes. Adults in the 12-week study ate the same healthy, pre-prepared foods, however, one group ate the bulk of their calories before 1 p.m. each day, versus the other group that ate 50% of their calories after 5 p.m…” Click here for full story.
Scinece Daily: “Scientists have found that insulin has met an evolutionary cul-de-sac, limiting its ability to adapt to obesity and thereby rendering most people vulnerable to Type 2 diabetes…” Click here for full story.
Healio: “Results from a randomized controlled trial showed that metformin provided cardiovascular benefits to patients with chronic kidney disease and metabolic syndrome…” Click here for full story.
Medscape: “Mario Buelna, a healthy 28-year-old father, caught a fever and started having trouble breathing in June. He soon tested positive for COVID-19… At 3 a.m. on Aug. 1, he passed out on the floor of his home in Mesa, Arizona. Paramedics rushed him to a nearby hospital… Their diagnosis – type 1 diabetes – stunned and frightened him. …” Click here for full story.
Science Daily: “An academic has helped draw up a landmark agreement amongst international experts, setting out the world’s first standard guidance on how people with diabetes can use modern glucose monitoring devices to help them exercise safely…” Click here for full story.
Healio: “Adults with diabetes admitted to a New York City hospital with COVID-19 had a lower mortality risk if they received a statin, according to a study published in the Journal of the American Heart Association…” Click here for full story.
ScienceDaily: “What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells…” Click here for full story.
Medscape: “A class of drugs long used to treat HIV and hepatitis B viral infections appears to prevent the development of diabetes in a substantial proportion of patients who take these agents, an analysis of multiple databases has shown…” Click here for full story.
ScienceDaily: “Drinking plenty of both green tea and coffee is linked to a lower risk of dying from any cause among people with type 2 diabetes, suggests research published in the online journal BMJ Open Diabetes Research & Care…” Click here for full story.
MedicalNewsToday: “New research conducted in mice has shown how coxsackievirus B type 4 — an enterovirus, a virus transmitted through the intestines — may be able to trigger diabetes in people who have the virus….” Click here for full story.
Healio: “An investigational once-daily pill added to optimized insulin therapy was shown to reduce HbA1c among adults with type 1 diabetes during a 12-week trial when compared with placebo plus insulin, according to a presenter…” Click here for full story.
Medscape: “Neither diabetes per se nor hyperglycemia appear to impair the antibody response to SARS-CoV-2, suggesting that a COVID-19 vaccine would be just as effective in people with diabetes as in those without, new research finds…” Click here for full story.
Healio: “Daily vitamin D supplementation to achieve blood levels of vitamin D higher than typically recommended for bone health may reduce risk for type 2 diabetes among adults with prediabetes, according to a new analysis of the D2d study…” Click here for full story.
ScienceDaily: “Researchers may have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes blood sugar and insulin resistance. The unexpected and surprising discovery raises the possibility of using electromagnetic fields (EMFs) as a remote control to manage type 2 diabetes…” Click here for full story.
Medscape: “With high rates of fatty liver disease known to occur among people with type 2 diabetes, is it time to introduce routine liver screening into daily diabetes practice? The answer depends on whom you ask, and then there are still some important caveats…” Click here for full story.
Wired: “From the outset of the pandemic, data coming out of early coronavirus hot spots like China, Italy, and New York City foretold that certain groups of people would be more vulnerable to Covid-19… As early as February, diabetes had emerged as one of the conditions associated with the highest risk…” Click here for full story.
Science Daily: “People who have been diagnosed with obstructive sleep apnea could be at increased risk of adverse outcomes from COVID-19, according to a new study…” Click here for full story.
Healio: “Participants in the Diabetes Remission Clinical Trial’s counter-weight plus intervention had a higher diabetes remission rate and were projected to have lower lifetime health care costs compared with controls, according to study data…” Click here for full story.
Science Daily: “A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates…” Click here for full story.
UPI: “Often-used drugs called proton pump inhibitors, or PPIs, ease heartburn symptoms, but a new study suggests they might also increase the risk of type 2 diabetes…” Click here for full story.
Medscape: “Patients with type 1 diabetes who have had a telemedicine appointment during the COVID-19 pandemic have generally found them favorable and would consider future remote visits, a new survey of more than 7000 people in 89 countries suggests…” Click here for full story.
Healio: “The FDA granted breakthrough therapy designation to the SGLT2 inhibitor dapagliflozin for adults with chronic kidney disease with and without type 2 diabetes, according to an industry press release…” Click here for full story.
Science Daily: “Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers have now identified biomarkers that can show in advance how the patient will respond to metformin treatment via a simple blood test…” Click here for full story.
Healio: “A high hemoglobin glycation index is associated with an increased risk for incident chronic kidney disease during 10 years of follow-up among treatment-naive adults with prediabetes or type 2 diabetes, according to a speaker…” Click here for full story.
Science Daily: “Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, scientists say. They suggest that drugs used to lower inflammation in the lungs could prove beneficial to obese patients with the disease…” Click here for full story.
News-Medical.net: “New research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls…” Click here for full story.
Healio: “A $35 insulin copay card Eli Lilly introduced in response to the COVID-19 pandemic has been added to the company’s insulin affordability programs, according to a press release...” Click here for full story.
News-Medical.net: “Drinking eight or more alcoholic beverages a week may increase the risk of high blood pressure (also called hypertension) among adults with Type 2 diabetes, according to new research published today in the Journal of the American Heart Association…” Click here for full story.
Science Daily: “The diabetes drug metformin has been prescribed to hundreds of millions of people worldwide as the frontline treatment for type 2 diabetes. Now, researchers have shown…that proteins, regulated by metformin, controlled aspects of inflammation in mice, something the drug has not typically been prescribed for...” Click here for full story.
Medscape: “Black children with type 1 diabetes in the United States are far less likely than white children to be prescribed insulin pumps, even among those with private health insurance, new research suggests…” Click here for full story.
Healio: “The FDA approved two additional doses of the once-weekly GLP-1 receptor agonist dulaglutide, expanding the drug’s label to include 3 mg and 4.5 mg doses, according to an industry press release...” Click here for full story.
Science Daily: “A simple test such as the strength of your handgrip could be used as a quick, low-cost screening tool to help healthcare professionals identify patients at risk of type 2 diabetes...” Click here for full story.
Healio: “The FDA approved a next-generation hybrid closed-loop insulin delivery system for children aged 2 to 6 years with type 1 diabetes, according to an agency press release…” Click here for full story.
Medscape: “Today I’m going to discuss the return to school this fall. There are two scenarios I want to talk about. The first is young adults with type 1 diabetes (T1D) who are leaving home and going off to college. They have their own set of risks and concerns. Second are parents who have T1D whose young kids are going back to school…” Click here for full story.
Medical Dialogues: “A recent study published in Diabetes Care has reported that metformin use is associated with early risk of anemia in individuals with type 2 diabetes, a finding which is claimed to be consistent across two RCTs and replicated in one real-world study...” Click here for full story.
MedpageToday: “In chronic kidney disease (CKD), dapagliflozin (Farxiga) reduced renal events and substantially improved overall survival, regardless of diabetes status, the DAPA-CKD trial showed…” Click here for full story.
Science Daily: “Losing weight could prevent or even reverse diabetes, according to late breaking research presented today at ESC Congress 2020...” Click here for full story.
Medical Xpress: “Many children may have delayed diagnosis of type 1 diabetes during the COVID-19 pandemic, according to a study published online Aug. 10 in Diabetes Care...” Click here for full story.
Healio: “Continuous glucose monitoring not only leads to better glycemic management for people with diabetes, but could also lead to cost savings, according to a speaker at Heart in Diabetes…” Click here for full story.
Healio: “Type 1 diabetes does not increase risk for hospitalization from COVID-19, particularly among individuals without diabetes complications, according to an analysis of hospital data…” Click here for full story.
Science Daily: “A new study, published in Nutrition and Metabolism, from researchers with the University of Alabama at Birmingham’s Nutrition Obesity Research Center observed improvements in body composition, fat distribution and metabolic health in response to an eight-week, very low-carbohydrate diet…” Click here for full story.
Medscape: “A smartphone app (Azumio Instant Heart Rate) may be a non-invasive method for identifying individuals with diabetes by detecting a “digital biomarker” of vascular changes, new research suggests…” Click here for full story.
Science Daily: “Air pollution is the world’s leading environmental risk factor, and causes more than nine million deaths per year. New research shows air pollution may play a role in the development of cardiometabolic diseases, such as diabetes. Importantly, the effects were reversible with cessation of exposure…” Click here for full story.
Medscape: “Accumulating observational data suggest that metformin use in patients with type 2 diabetes might reduce the risk for death from COVID-19, but the randomized trials needed to prove this are unlikely to be carried out, according to experts…” Click here for full story.
Medscape: “Two UK analyses of risk factors linked to COVID-19 mortality in people with type 1 and type 2 diabetes that were issued as preprints have now been peer reviewed and were published in The Lancet Diabetes and Endocrinology…” Click here for full story.
Science Daily: “Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications…” Click here for full story.
Healio: “Good skin care and proper use of wearable diabetes technology can help prevent skin issues related to insulin pump or continuous glucose monitor use, according to two speakers…” Click here for full story.
Yahoo: “An arthritis drug that could delay the progression of type 1 diabetes has been hailed as “life changing”. The autoimmune condition comes about when a patient’s body mistakenly attacks cells that produce the blood-sugar lowering hormone insulin…” Click here for full story.
Healio: “Adults with type 2 diabetes who replaced their usual breakfast and an afternoon or evening snack with a nutritional shake experienced a 47% reduction in postmeal peak glucose after breakfast, according to findings from a pilot study…” Click here for full story.
Medscape: “New guidance from the UK National Diabetes COVID-19 Response Group addresses glucose management in patients with COVID-19 who are receiving dexamethasone therapy…” Click here for full story.
The Beet: “A new study just published finds that plant-based diets help you metabolize glucose, lose weight (especially in overweight people) and avoid type 2 diabetes. The study, from the University of Bergen in Norway, looked at different plant-based diets…” Click here for full story.
Healio: “Risks for ICU admission and death from COVID-19 are higher for adults with diabetes and hypertension, but the number of COVID-19 patients with diabetes and hypertension may be lower than previously reported…” Click here for full story.
Psychology Today: “You might not think that diabetes and dementia have anything in common. But they have a common risk factor when it comes to one protective behavior. And that’s our “one word” for the day…” Click here for full story.
Medscape: “The risk for heart attack, stroke, and even death increases as the severity of diabetic retinopathy increases. Severe retinopathy is linked to a doubling of the risk for cerebrovascular accident or myocardial infarction, results from a new study show…” Click here for full story.
Science Daily: “Researchers have found an unusual strategy that eventually may help to guard transplanted beta cells or to slow the original onset of type 1 diabetes…” Click here for full story.
Healio: “The FDA approved an 8% capsaicin patch for the treatment of adults with neuropathic pain associated with diabetic peripheral neuropathy of the feet, according to an industry press release…” Click here for full story.
Reuters: “Darrell Cager Sr., 64, had diabetes. So his youngest daughter urged him to seek care. The next day, he collapsed and died in his New Orleans home. The daughter soon learned the cause: acute respiratory distress from COVID-19...” Click here for full story.
Science Daily: “Some benefits of aerobic exercise may be dampened by higher-than-normal blood sugar levels, a condition known as hyperglycemia. These diminished gains are seen in mouse models and humans with chronic hyperglycemia that is in the ‘prediabetes’ range...” Click here for full story.
Healio: “Influenza vaccination was significantly associated with reduced risks for all-cause death, cardiovascular death, and death from acute myocardial infarction or stroke among adults with diabetes, according to an analysis of registry data...” Click here for full story.
Healio: “New Hampshire Gov. Chris Sununu signed into law an omnibus bill that will limit cost sharing for insulin to $30 for a 30-day supply for those with state-regulated commercial health insurance, according to a press release…” Click here for full story.
Science Daily: “Scientists have developed a simple clinical test that can assess the lower limb strength of patients to predict their risk of falls. The ‘enhanced paper grip test’ involves pulling a small card from underneath the participant’s foot while asking them to grip with their big toe (Hallux)...” Click here for full story.
ScienceDirect: “The CoV-19 infection appears to be unusual among patients with type 1 Diabetes Mellitus, although they are considered a fragile population. We think that this in part due to the peculiar immune condition that leads to the destruction of the Beta cells…” Click here for full story.
Science Daily: “A new study by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine documents a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2 diabetes…” Click here for full story.
1010 WINS: “Two more drug manufacturers have recalled the widely-used Type 2 diabetes medication metformin, over concerns that it contains too much of the human carcinogen NDMA, a ‘probable’ cancer-causing substance, the FDA announced this week...” Click here for full story.
Medscape: “Nearly half of hospitalized COVID-19 patients without a prior diabetes diagnosis have hyperglycemia, and the latter is an independent predictor of mortality at 28 days, new research indicates…” Click here for full story.
MedPage Today: “The goal of this study was to compare benefits and harms of different glucose-lowering drugs in adults with type 2 diabetes. Question Addressed: What were the benefits and harms of different glucose-lowering drugs in adults with type 2 diabetes?..” Click here for full story.
Science Daily: “People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society...” Click here for full story.
Healio: “Diabetic ketoacidosis is a common and potentially fatal complication in hospitalized patients with COVID-19, according to a new clinical perspective.Adults diagnosed with type 2 diabetes before age 30 years are more likely to develop renal failure over time compared with those with a shorter diabetes duration, according to a database analysis published in Diabetes Care...” Click here for full story.
Medscape: “The largest network meta-analysis of diabetes drugs to date indirectly compared 21 glucose-lowering drugs for adults with type 2 diabetes in nine drug classes and 453 trials — to help guide therapy in a ‘challenging, complex landscape’…” Click here for full story.
Science Daily: “Diabetic ketoacidosis is a common and potentially fatal complication in hospitalized patients with COVID-19, according to a new clinical perspective…” Click here for full story.
Healio: “For patients with type 2 diabetes or the APOL1-HR genotype, a machine learning test integrating biomarkers and electronic health record data demonstrated improved prediction of kidney failure compared with commonly used clinical models….” Click here for full story.
Science Daily: “Progression of kidney disease in type 1 diabetes is correlated with increased amounts of uric acid. A drug that reduces uric acid levels was tested in a multi-institution randomized clinical trial. Though the study did not show the desired clinical benefit, it did provide a very clear answer to an important scientific question…” Click here for full story.
Medscape: “Women taking the widely used oral diabetes medication metformin may be at lower risk for fatal COVID-19, according to a study posted on Saturday that has not yet been peer-reviewed…” Click here for full story.
MedPage Today: “Can a glucagon-like peptide-1 (GLP-1) receptor agonist lower cognitive decline in type 2 diabetes? An exploratory analysis of the dulaglutide (Trulicity) cardiovascular outcome trial suggests so…” Click here for full story.
Science Daily: “Prevention or delay of type 1 diabetes could become a reality in the next few years, with teplizumab (PRV-031, Provention Bio) likely to become the first agent commercially available to halt disease progression…” Click here for full story.
Science Daily: “Early signs of being more susceptible to type 2 diabetes as an adult can be seen in children as young as 8 years old, decades before it is likely to be diagnosed, according to a new study…” Click here for full story.
Healio: “Alternative, patient-tailored strategies are needed to treat diabetic ketoacidosis in the setting of COVID-19 to better balance intensive insulin therapy with minimizing clinician exposure and preserving personal protective equipment…” Click here for full story.
Seeking Alpha: “The FDA approves Evoke Pharma’s Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis, a disorder in which the stomach’s contractions are disrupted compromising digestion…” Click here for full story.
Healio: “Celiac disease as a comorbidity of type 1 diabetes is often asymptomatic, and people with both diseases should closely monitor glucose levels during transition to a gluten-free diet, according to a study…” Click here for full story.
Science Daily: “Alternative, patient-tailored strategies are needed to treat diabetic ketoacidosis in the setting of COVID-19 to better balance intensive insulin therapy with minimizing clinician exposure and preserving personal protective equipment…” Click here for full story.
Medscape: “Glycemic control among youth with diabetes is no better today than it was in 2002 and in some subgroups it’s worse, despite increased availability of diabetes technology, newer therapies, and more aggressive recommended blood glucose targets, new research finds…” Click here for full story.
Science Daily: “Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes…” Click here for full story.
Healio: “Among U.S. adults with type 2 diabetes attending primary care and endocrinology clinics, less than 40% of those found to have liver fibrosis had elevated aspartate aminotransferase and alanine aminotransferase, according to study data…” Click here for full story.
Medscape: “The SENZA-PDN study results were presented as a late-breaking poster presentation at the virtual annual scientific sessions of the American Diabetes Association. Those results included 103 patients randomized to conventional medical management alone, and 113 who received medical management plus the spinal cord stimulator…” Click here for full story.
Healio: “The FDA has cleared a next-generation integrated continuous glucose monitoring system for adults and children aged 4 years and older with diabetes, according to a press release from Abbott…” Click here for full story.
Healio: “Since early March, experts have undertaken a flurry of new study and guidance for treating endocrine conditions in the setting of COVID-19. Debate continues over the risks for worse disease outcomes, optimal management and best treatments…” Click here for full story.
Medscape: “Experts may be moving toward accepting cannabis as a useful tool to treat neuropathic pain (NP), a recent debate on the topic suggests…” Click here for full story.
Science Daily: “A research team has discovered that metformin, the most widely prescribed anti-diabetic drug, causes sugar to be excreted in the stool. Taking advantage of the new bio-imaging apparatus PET-MRI, they revealed that metformin promotes the excretion of blood sugar from the large intestine into the stool. This is a completely new discovery that was not previously anticipated…” Click here for full story.
Healio: “The FDA has asked five drug manufacturers to voluntarily recall several lots of extended-release metformin after agency lab testing revealed unacceptable levels of the nitrosamine impurity N-Nitrosodimethylamine, or NDMA…” Click here for full story.
CNN: “One in 10 coronavirus patients with diabetes died within the first seven days of hospitalization, and one in five needed a ventilator to breathe, according to a new study by French researchers…” Click here for full story.
Medscape: “In the search for silver linings from the COVID-19 pandemic, this is at least a short-term one: adults with type 1 diabetes confined at home during quarantine were better able to keep their blood glucose levels in target range, according to two new studies…” Click here for full story.
Medscape: “Adults and children with type 1 diabetes will spend an average of $2,500 a year out-of-pocket for health care – but insulin isn’t always the biggest expense – new research suggests…” Click here for full story.
Healio: “A new National Kidney Foundation-Harris poll on COVID-19 and kidney health indicates less than one in five Americans are aware that kidneys can fail due to coronavirus…” Click here for full story.
Science Daily: “Eating at least two daily servings of dairy is linked to lower risks of diabetes and high blood pressure, as well as the cluster of factors that heighten cardiovascular disease risk (metabolic syndrome), finds a large international study…” Click here for full story.
Medscape: “A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk management in people with diabetes and offers suggestions for an optimal approach for those hospitalized with the infection…” Click here for full story.
New Atlas: “One of the disastrous effects of diabetes is the harm it can cause to the retina, with this degeneration of blood vessels in the eye now the leading cause of new blindness in working-age adults. An international team of scientists has developed technology that could pick up this so-called diabetic retinopathy in its early stages, using a standard smartphone…” Click here for full story.
PR Newswire: “A new research study published in Current Developments in Nutrition found that the equivalent of one cup of fresh blueberries, given as 22 g of freeze-dried blueberries, may beneficially affect areas of health in overweight men with type 2 diabetes…” Click here for full story.
Healio: “AstraZeneca announced the FDA has approved its SGLT2 inhibitor dapagliflozin to reduce risk for CV death and HF hospitalization in patients with HF with reduced ejection fraction with and without type 2 diabetes…” Click here for full story.
Medscape: “The story of COVID-19 and the science behind the pandemic is evolving rapidly every day, with a flurry of publications in various clinical and preclinical journals. Here, I summarize the known and unknown links between diabetes and COVID-19, focusing on three pertinent clinical questions…” Click here for full story.
Science Daily: “According to many observations, certain virus infections may play a part in the autoimmune attack that leads to type 1 diabetes. Researchers have now produced a vaccine for these viruses in the hope that it could provide protection against the disease…” Click here for full story.
Healio: “Patients with chronic diseases aged older than 65 years, particularly those with cardiovascular disease or diabetes, are at significantly greater risk for acquiring COVID-19 and subsequent mortality from the virus, according to findings presented during a CDC webinar…” Click here for full story.
Science Daily: “Use of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, finds a study published by The BMJ today…” Click here for full story.
Science Daily: “A new study adds to the evidence that people with type 2 diabetes (T2D) are at greater risk of a poor outcome should they become infected with the virus that causes COVID-19. But there is some encouraging news: people with T2D whose blood sugar is well controlled fare much better than those with more poorly controlled blood sugar…” Click here for full story.
Healio: “Older men with sarcopenia are more likely to develop type 2 diabetes during 15 years of follow-up compared with men who have more lean body mass, according to findings published in the Journal of the Endocrine Society...” Click here for full story.
Reuters: “Britain’s AstraZeneca is testing a diabetes drug as a potential treatment for COVID-19 patients who also had existing heart and kidney problems, its second trial of an approved therapy to help treat the disease caused by the coronavirus…” Click here for full story.
Science Daily: “Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®…” Click here for full story.
Healio: “The risk for severe COVID-19 complications is significantly higher for people with diabetes, and glucose management may play a vital role in disease outcomes. At the same time, careful monitoring of inpatient glucose can prove unsafe for clinicians and nurses…” Click here for full story.
Medsacpe: “There has been a massive decline in outpatient office visits as patients have stayed home — likely deferring needed care — because of COVID-19, new research shows…” Click here for full story.
Harvard Medical School: “Preliminary data from China suggest that people with diabetes and other preexisting conditions are more likely to experience serious complications and death from COVID-19 than people without diabetes and other conditions…” Click here for full story.
The New York Times: “Women born by cesarean section had a higher risk for developing Type 2 diabetes decades later…” Click here for full story.
Healio: “Insulin — not DPP-IV inhibitors or GLP-1 receptor agonists — should be the agent of choice for the management of severely ill patients with diabetes and coronavirus infections; this position is supported by extensive historical experience and the increased adoption of continuous glucose monitoring, according to a literature review published in Endocrine Reviews…” Click here for full story.
Science Daily: “Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is because the glucagon-secreting α-cells have become resistant to insulin…” Click here for full story.
Medscape: “Here is another update on what we know about COVID-19 in people with diabetes. The data that we have suggest that people with diabetes are actually not at increased risk for catching the novel coronavirus, but once they become infected, they may do less well, particularly if they’re in an ICU setting…” Click here for full story.
U.S. News & World Report: “If you or someone you love has diabetes, you’ve probably noticed that diabetes always pops up on lists of people at higher risk from COVID-19 infections. And you’ve probably wondered why…” Click here for full story.
MedPage Today: “In patients with type 2 diabetes undergoing surgery, metformin appeared to offer some protection against poor outcomes, researchers reported…” Click here for full story.
Medscape: “Whether the motivation is animal or worker welfare, environmental sustainability, personal taste or something else, people with diabetes can safely adopt a plant-based diet. In fact, vegetarian and vegan eating patterns have been shown to improve cardiovascular disease and glucose management…” Click here for full story.
Science Daily: “A new study reports valuable new grip strength metrics that provide healthcare practitioners with an easy-to-perform, time-efficient screening tool for type 2 diabetes (T2DM)…” Click here for full story.
Forbes: “Researchers have warned that hydroxychloroquine (HCQ) and chloroquine (CQ), two similar drugs repeatedly touted by President Trump to be promising treatments for COVID-19, may be toxic when combined with a common diabetes drug…” Click here for full story.
Science Daily: “Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new article…” Click here for full story.
USA Today: “While the masses hunt for toilet paper, Caroline Gregory and other people with diabetes are on a different mission: scouring stores for the rubbing alcohol or alcohol swabs needed to manage their disease…” Click here for full story.
Healio: “The COVID-19 pandemic has forced health care institutions around the country and around the globe to change the way they practice medicine. Clinicians at Joslin Diabetes Center — the world’s largest diabetes research center, diabetes clinic and provider of diabetes education —ramped up the organization’s telehealth capabilities within a week’s time to provide remote care for routine and nonurgent appointments, while fielding questions from anxious patients about access to medications and risks for worse coronavirus complications that can come with poorly controlled diabetes…” Click here for full story.
Healio: “As the COVID-19 pandemic continues to worsen, endocrinologists are confronting changes large and small to the way they practice medicine. For some… it means navigating an unprecedented, nationwide shift to telemedicine and virtual communication, all while prioritizing the patients who still urgently need an in-person consultation and the risks that come with it…” Click here for full story.
Medscape: “Reports from pediatric endocrinologists in COVID-19 hotspots globally indicate that children, adolescents, and young adults with diabetes have so far not shown a different disease pattern with the virus compared to children and younger people who do not have diabetes…” Click here for full story.
Medical Xpress: “As the COVID-19 pandemic continues to worsen, endocrinologists are confronting changes large and small to the way they practice medicine. For some… it means navigating an unprecedented, nationwide shift to telemedicine and virtual communication, all while prioritizing the patients who still urgently need an in-person consultation and the risks that come with it…” Click here for full story.
Healio: “Patients with knee osteoarthritis demonstrated higher average pain intensity and worse physical and mental health if they also have diabetes, according to data published in Arthritis Care & Research…” Click here for full story.
Medscape: “Patients with diabetes may be at extra risk for coronavirus disease (COVID-19) mortality, and doctors treating them need to keep up with the latest guidelines and expert advice…” Click here for full story.
The Hill: “While estimates suggest that hundreds of millions of Americans may contract the coronavirus, the complications experienced by those infected will vary widely. The whole point of ‘flattening the curve’ is to ensure that those who are most in need of medical resources — the elderly and those with underlying health conditions — can receive medical attention when they need it…” Click here for full story.
Healio: “Children who are diagnosed with type 1 diabetes under the age of seven have a different form (or ‘endotype’) of the condition compared with those diagnosed aged 13 or above, new research has shown…” Click here for full story.
Healio: “The FDA on Friday issued a complete response letter for a supplemental new drug application for a 2.5 mg dose of the SGLT2 inhibitor empagliflozin as an adjunct to insulin for adults with type 1 diabetes, according to a press release from Boehringer Ingelheim and Eli Lilly…” Click here for full story.
CDC.gov: “COVID-19 is a new disease and we are learning more about it every day. Older adults and people of any age who have serious underlying medical conditions may be at higher risk for more serious complications from COVID-19. Based upon available information to date, those most at risk include…” Click here for full story.
CNBC: “Many Americans will be exposed to COVID-19 over the next year or so with many people in the U.S. getting sick, a top CDC official said Monday, recommending that people over 60 and anyone with chronic medical conditions buckle down for a lengthy stay home…” Click here for full story.
Medscape: “I’ve been getting many calls from my patients with diabetes who are understandably concerned about COVID-19 and their risk, so I thought this would be an important topic for us to discuss…” Click here for full story.
Healio: “As the country struggles to come up with a public health response to the novel coronavirus pandemic, endocrinologists are warning people with type 1 and type 2 diabetes of their increased susceptibility for contracting the disease and how to best be prepared with an adequate supply of diabetes medications and testing supplies…” Click here for full story.
Healio: “New Mexico Gov. Michelle Lujan Grisham on Wednesday signed legislation capping monthly copayments for insulin at $25, the lowest copay cap introduced at the state level and the latest state effort to stem the rising cost of the drug, according to a press release from the governor’s office…” Click here for full story.
The Hill: “Virginia lawmakers have passed a bill that will force insurers to cap insulin costs at $50 a month, sending the bill to Gov. Ralph Northam’s (D) desk for signature…” Click here for full story.
Healio: “Patients who consumed at least 7 g per day of olive oil had lower risk for CHD and total CVD compared with those who did not consume it, according to data presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions…” Click here for full story.
Medscape: “Patients with severe obesity and diabetes who are contemplating bariatric surgery now have data to make a better-informed decision, researchers report. A large, multicenter US study of such patients has identified similarities and differences in 5-year diabetes remission, diabetes relapse, and glycemic control after the two most common types of bariatric surgery…” Click here for full story.
Healio: “A higher volume of steps per day in middle-aged adults lowered the risk for type 2 diabetes and stage 2 hypertension, according to data presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions…” Click here for full story.
Healio: “Chinese adults with type 1 diabetes can avoid insulin-related weight gain and use less insulin by adding metformin to treatment regimens, according to findings published in the Journal of Diabetes…” Click here for full story.
Science Daily: “The circadian clock system allows the organisms to adjust to periodical changes of geophysical time. Today, increasing evidence show that disturbances in our internal clocks stemming from frequent time zone changes, irregular working schedules or ageing, have a significant impact on the development of metabolic diseases including type-2 diabetes…” Click here for full story.
Medscape: “Americans with diabetes are experiencing more financial hardship from medical bills than those without diabetes, even when they have health insurance, new research shows…” Click here for full story.
FiercePharma: “As questions about suspected carcinogens in drugs continue to roil the supply chain, the FDA last month said its testing of metformin did not find any with unacceptably high levels of NDMA. But testing laboratory Valisure has challenged those findings in a new Public Citizen petition, saying it discovered problems in 42% of the batches it checked. It contends the situation is likely to get worse as the COVID-19 outbreaks wreak havoc on supply chains…” Click here for full story.
Healio: “Thyroid dysfunction is common among people with diabetes regardless of type, suggesting that biochemical thyroid screening should be a part of routine management for those with type 1 and type 2, according to an analysis of a community-based study published in Clinical Endocrinology…” Click here for full story.
Science Daily: “A healthy diet is essential to living well, but should we change what we eat as we age? Researchers have found strong evidence of the link between food groups and memory loss and its comorbidities. Her findings point to a need for age-specific dietary guidelines as the links may vary with age — people aged 80+ with a low consumption of cereals are at highest risk of memory loss and comorbid heart disease…” Click here for full story.
Healio: “The FDA approved the GLP-1 receptor agonist dulaglutide for the reduction of major adverse cardiovascular events for adults with type 2 diabetes who have established cardiovascular disease or multiple CV risk factors, making it the first type 2 diabetes drug approved for primary and secondary prevention populations, according to a press release from Eli Lilly…” Click here for full story.
Medscape: “Among women with a history of gestational diabetes, a longer period of breastfeeding was associated with a lower probability of going on to develop type 2 diabetes, as well as a more favorable glucose metabolic biomarker profile. Women who breastfed for 2 years or longer had a 27% lower risk than that of those who did not breastfeed at all…” Click here for full story.
Healio: “An investigational, once-daily pill added to optimized insulin therapy was shown to reduce HbA1c among adults with type 1 diabetes during a 12-week trial when compared with placebo plus insulin, according to a press release from vTv Therapeutics…” Click here for full story.
Science Daily: “Women who sleep poorly tend to overeat and consume a lower-quality diet, according to a new study from researchers at Columbia University Irving Medical Center. The findings provide new insight into how poor sleep quality can increase the risk of heart disease and obesity and points to possible interventions for improving women’s heart health…” Click here for full story.
Healio: “Adults with type 2 diabetes who lose enough weight to enter diabetes remission are also able to recapture normal beta-cell capacity, according to findings published in Diabetes Care…” Click here for full story.
Harvard Health News: “A recent study published in JAMA Cardiology looked at whether the ideal cardiovascular (CV) metrics covered in Life’s Simple 7 translate into improved CV health for those with T2D or prediabetes. The results were exciting, and consistent with other large population-based studies…” Click here for full story.
Medscape: “The US Food and Drug Administration (FDA) says it has no plans to recall any metformin products, used for the treatment of type 2 diabetes, after tests it conducted did not show any evidence of contamination with N-nitrosodimethylamine (NDMA) at levels that would cause concern…” Click here for full story.
Science Daily: “A new study published by The BMJ today adds to evidence that rosiglitazone — a drug used to treat type 2 diabetes — is associated with an increased risk of heart problems, especially heart failure…” Click here for full story.
Medscape: “A partnership between the Department of Veterans Affairs and Silicon Valley startup Virta Health Corp. is focusing attention on the company’s claim that it provides treatment ‘clinically-proven to safely and sustainably reverse type 2 diabetes’ without medication or surgery…” Click here for full story.
Healio: “A peer-delivered, cognitive behavioral therapy-based intervention improved functioning, pain, quality of life and self-reported physical activity in patients with diabetes and chronic pain, researchers reported in Annals of Family Medicine…” Click here for full story.
Healio: “In hopes of helping ensure patients can take their medication as prescribed, CVS Caremark is offering employers and health insurers a solution that will eliminate out-of-pocket expenses for members, without costing either the employer or insurer more money…” Click here for full story.
Healio: “Eli Lilly and Co. will donate at least 200,000 KwikPens to three relief organizations to stock insulin at nearly 200 free clinics in the United States through 2022, according to an industry press release…” Click here for full story.
Medical Xpress: “The circadian clock system allows organisms to anticipate periodic changes of geophysical time and to adjust to those changes… Today, increasing evidence show that disturbances in internal clocks stemming from frequent time zone changes, irregular work schedules and aging have a significant impact on the development of metabolic diseases in human beings, including type-2 diabetes…” Click here for full story.
Science Daily: “A ketogenic diet — which provides 99 percent of calories from fat and only 1 percent from carbohydrates — produces health benefits in the short term, but negative effects after about a week, researchers found in a study of mice…” Click here for full story.
Chicago Tribune: “Illinois became one of the first states in the U.S. to limit the out-of-pocket price of insulin when Gov. J.B. Pritzker signed a measure on Friday that caps the cost of medication people with diabetes rely on.” Click here for full story.
Biospace: “Eli Lilly is adding additional reduced cost insulin options to patients. The Indianapolis-based company announced lower-priced versions of Humalog Mix75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100 units/mL) and Humalog Junior KwikPen (insulin lispro injection 100 units/mL).” Click here for full story.
Crain’s Detroit Business: “Meijer Pharmacy has stopped offering two medications for free: type 2 diabetes drug metformin and cholesterol-lowering atorvastatin. The Grand Rapids-based pharmacy…said it will continue to offer the most commonly prescribed antibiotics along with prenatal vitamins for no charge to all customers.” Click here for full story.
Healio: “Community-based HbA1c testing in barbershops may help identify black men with undiagnosed diabetes, according to a research letter published in JAMA Internal Medicine.” Click here for full story.
Healio: “Adults with diabetes of any BMI have lower mortality risk if they are more physically fit, although the “obesity paradox” still holds for less fit people, according to findings published in Diabetes Care...” Click here for full story.
BioSpace: “Danish company Novo Nordisk specializes in the diabetes market. The company appears to be making an entry into the Alzheimer’s market, which isn’t as unusual or unexpected as it initially sounds. It has been postulated for some time that Alzheimer’s disease is related to blood glucose levels and has been dubbed type 3 diabetes…” Click here for full story.
Healio: “Nonalcoholic fatty liver disease, or NAFLD, a condition traditionally treated by hepatologists, is widespread and frequently associated with obesity, insulin resistance, diabetes and other metabolic risk factors. Type 2 diabetes appears to worsen the course of NAFLD and promote development of nonalcoholic steatohepatitis, or NASH, the more severe form of the disease…” Click here for full story.
Healthline: “Dates are the sweet, fleshy fruits of the date palm tree. They’re typically sold as dried fruit and enjoyed on their own or in smoothies, desserts, and other dishes. Due to their natural sweetness, their impact on blood sugar may be a concern for those with diabetes…” Click here for full story.
Yahoo! Finance: “The FDA has of late been prioritizing approvals for the new-generation and advanced line of diabetes management devices… While diabetes management companies are coming up with cutting-edge innovation to gain traction in this niche market, there are a few stocks that deserve investors’ attention now. Let us take a closer look.” Click here for full story.
Medscape: “Ever since the U.S. Food and Drug Administration (FDA) mandated cardiovascular outcome trials (CVOTs) for all diabetes medications, these trials have hogged the limelight in diabetes-related news… But now, for the first time in several years, an FDA-mandated CVOT is not leading the list of the year’s top diabetes news!” Click here for full story.
Science Daily: “With more people with diabetes and pre-diabetes looking for novel strategies to help control blood sugar, new research suggests that ketone monoester drinks — a popular new food supplement — may help do exactly that…” Click here for full story.
Healio: “Type 2 diabetes risk may be higher even after more than 20 years for Chinese women who develop gestational diabetes compared with those who do not, according to findings published in the Journal of Diabetes Investigation…” Click here for full story.
Loma Linda University Health: “Loma Linda University Health is seeking volunteers with moderate to severe below-ankle neuropathy for a graduate student research study titled The Effect of Intraneural Facilitation Therapy on Diabetic Patients with Peripheral Neuropathy. The study hypothesizes that Intraneural Facilitation therapy (INF™) — a treatment that uses three physical holds to stretch specific nerve areas and bring pressurized blood flow to damaged nerves — may relieve patients with diabetic neuropathy of pain and discomfort…” Click here for full story.
Reuters: “Novo Nordisk said on Thursday it would offer free, one-time supply of insulin to people in immediate need and at risk of rationing the medication, the rising price of which has attracted fierce criticism from lawmakers and regulators…” Click here for full story.
Healio: “The FDA on Monday approved fast-acting insulin aspart 100 U/mL as a mealtime insulin for children with diabetes, according to a press release from Novo Nordisk. Fast-acting insulin aspart (Fiasp) is the first and only fast-acting mealtime insulin injection that does not have a premeal dosing recommendation, according to Novo Nordisk…” Click here for full story.
Medscape: “For the third year in a row, the Mediterranean diet has been named the best diet overall in the U.S. News & World Report annual rankings. In 2018, the Mediterranean diet shared top honors with the DASH (Dietary Approaches to Stop Hypertension) diet…” Click here for full story.
Healio: “Prediabetes was less likely to progress to type 2 diabetes among adults who took a combination of linagliptin and metformin vs. metformin alone; the combination group was also more likely to achieve normal glucose levels, according to findings published in Metabolism…” Click here for full story.
The Washington Post: “No, you don’t get it from eating too many sweets. More than 100 million U.S. adults live with diabetes or prediabetes, making the disease one of the most serious health risks in modern society…” Click here for full story.
Good News Network: “A ‘breakthrough’ treatment plan for type-2 diabetes has the British National Health Service (NHS) bustling as they position themselves to adopt a new standard of treatment. The course of treatment consists of a liquid diet of 800 calories to be taken as a soup or shake daily for a set amount of months depending on the time since the patient developed type-2 diabetes…” Click here for full story.
Boston Herald: “An artificial pancreas system that automatically monitors and regulates blood glucose levels will reduce constant worry and self-care for Type 1 diabetes patients and is being hailed as a breakthrough by one of Boston’s top diabetes doctors…” Click here for full story.
The Verge: “A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will reach patients in January 2020…” Click here for full story.
Medscape: “High consumption of so-called ultra-processed foods is associated with an increased risk of type 2 diabetes, independent of other risk factors including weight and nutritional quality of the diet, a new study indicates. The results suggest a possible modifiable target for prevention of diabetes, say the authors…” Click here for full story.
Healio: “Several cutting-edge advances in noninjectable insulin delivery methods could offer new ways for people with diabetes to manage the disease and better control glucose response, with the possibility of an oral insulin formulation closer than ever before to becoming reality, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease…” Click here for full story.
Science Daily: “Children with Type 1 diabetes show subtle but important differences in brain function compared with those who don’t have the disease, a study led by researchers at the Stanford University School of Medicine has shown…” Click here for full story.
MedPage Today: “Prediabetes has frequently been linked with insulin resistance syndrome (metabolic syndrome), which, in turn, is directly involved in the pathogenesis of type 2 diabetes. The three glucose abnormality phenotypes of prediabetes have also been associated with an increased risk for cardiovascular disease (CVD)…” Click here for full story.
Healthline: “Sometimes called “nature’s sports beverage,” coconut water has gained popularity as a quick source of sugar, electrolytes, and hydration. It’s a thin, sweet liquid, extracted from the inside of young, green coconuts. Unlike coconut meat, which is rich in fat, coconut water consists mostly of carbs…” Click here for full story.
Yahoo! News: “For many with diabetes, living a normal life can be difficult. And for families with children who may have the disease, it can be scary too. When 16-year-old Emily Setterstrom was diagnosed with Type 1 diabetes in kindergarten after suddenly experiencing rapid weight loss, her mom Jennifer Setterstrom, feared for her daughter’s life after losing her brother to the same disease…” Click here for full story.
Science Daily: “Metformin is the most commonly prescribed type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. Researchers have now used a novel technology to investigate why it functions so well. The findings could also explain why metformin has been shown to extend health span and life span in recent studies…” Click here for full story.
Healio: “Japanese adults with type 2 diabetes assigned a long-term low-dose aspirin regimen did not lower their risk for dementia vs. similar adults who did not routinely take aspirin, according to a post hoc analysis of the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial…” Click here for full story.
Medscape: “Limiting food consumption to a 10-hour window each day promotes weight loss and improves cardiometabolic abnormalities in women with metabolic syndrome, a small pilot study suggests…” Click here for full story.
Medical News Today: “Typically, doctors advise people with type 2 diabetes to eat about six times a day. But this approach can lead to a vicious cycle in which individuals require more intensive treatments. Could a different approach to diet be more suitable?” Click here for full story.
WNDU News: “There are more than a million people who have Type 1 diabetes, and they’re expected to live at least 10 years less than Americans without it. In fact, there are only 90 diabetics who have lived more than 70 years. But one man crushed that goal 15 years ago and is telling others how they can do it too…” Click here for full story.
Medical News Today: “Doctors commonly prescribe metformin to help people with type 2 diabetes lower their blood sugar levels. The drug increases insulin sensitivity through its effects on glucose metabolism…” Click here for full story.
Healio: “The FDA on Tuesday approved an expanded indication for insulin glargine injection 300 U/mL to improve glucose response in children aged 6 years and older with diabetes, according to a press release from Sanofi. Insulin glargine injection (Toujeo) 300 U/mL is a long-acting insulin previously approved to improve blood glucose in adults with diabetes…” Click here for full story.
Medscape: “Retail health clinics have been part of the trend in making healthcare more convenient, and now another option is being offered — testing for diabetic retinopathy. However, an ophthalmologist won’t make the diagnosis at the clinic; instead, it will be made by an artificial intelligence (AI) system called IDx-DR…” Click here for full story.
People: “Los Angeles Chargers quarterback Philip Rivers and wife Tiffany Rivers are hoping to raise awareness for type 1 diabetes after their son was diagnosed with the condition when he was just 5 years old. ‘It’s our everyday,’ Tiffany tells PEOPLE of her son, Gunner, being diagnosed with the condition six years ago. ‘It’s our normal. It’s definitely a part of our life now’…” Click here for full story.
Science Daily: “In a recent study using mice, lab-grown human retinal cells and patient samples, scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye…” Click here for full story.
Medical Xpress: “New results from The Environmental Determinants of Diabetes in the Young (TEDDY) study show an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes (T1D). Notably, researchers also found that early adenovirus C infection seemed to confer protection from autoimmunity. The full findings were published Dec. 2 in Nature Medicine…” Click here for full story.
TNW: “Brazilian and US scientists have developed a glasses-based biosensor capable of measuring blood glucose levels through a person’s tears, offering a less invasive test for diabetics. Glucose levels need to be frequently monitored in people with diabetes, a disease that affects 62 million people in the Americas and 380 million worldwide…” Click here for full story.
The New York Times: “Diabetes, whether Type 1 or Type 2, may be the most underappreciated, misunderstood and poorly treated of all common medical problems, and many of the more than 30 million Americans affected by it are paying dearly with their health and lives as a result. Contrary to what many people think, diabetes is not just a disease of abnormal blood sugar control caused by a lack of insulin or an inadequate response to this crucial hormone…” Click here for full story.
Medpage Today: “Patients with diabetic foot osteomyelitis (DFO) treated with rifampin (Rifadin) experienced better outcomes than those treated with other antibiotics, authors of a retrospective cohort study reported. In approximately 6,000 patients followed for 2 years, 26.9% of those who received an antibiotic combination including rifampin — best known as a tuberculosis treatment — died or had an amputation compared with 37.2% of those who received antibiotics other than rifampin (P=0.02)…” Click here for full story.
Miami Herald: “For many years, Abraham Aviv had suffered from nonalcoholic fatty liver disease… Non-alcoholic fatty liver disease is common in the type 2 diabetic population, said Dr. Kawtar Al Khalloufi, a hepatologist at Cleveland Clinic Florida-Weston, where Aziz was referred after being diagnosed with cirrhosis…” Click here for full story.
Healio: “Diabetes devices such as sensors, insulin pumps and continuous glucose monitors continue to improve, offering people with diabetes more opportunities for connected care… As new devices and updates for older technologies enter the market, endocrinologists, diabetes care and education specialists, and other providers can find themselves overwhelmed…” Click here for full story.
Science Daily: “Researchers found that age plays a critical role in the well-being of people newly diagnosed with Type 2 diabetes, with younger patients more susceptible to psychological distress resulting in worse health outcomes…” Click here for full story.
Medscape: “A U.S. Food and Drug Administration (FDA) advisory committee has recommended against approval of empagliflozin (Boehringer Ingelheim, Jardiance), a sodium-glucose cotransporter type 2 (SGLT2) inhibitor, as an adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes mellitus…” Click here for full story.
Oramed: “Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive results from the initial cohort of the Phase IIb trial evaluating the efficacy and safety of its lead oral insulin candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsule for the treatment of diabetes…” Click here for full story.
Healio: “Adults with type 2 diabetes can experience multiple diabetes-specific benefits beyond weight loss by undertaking a low-carbohydrate diet, although potential risks must be addressed, according to a speaker at ObesityWeek…” Click here for full story.
ABC 7: “Rationing insulin is not uncommon among people with diabetes. The average price of the drug has skyrocketed in recent years, leading some patients to go to desperate lengths to get it. The American Diabetes Association (ADA) reports the price of the drug has nearly tripled between 2002 and 2013…” Click here for full story.
WebMD: “Diabetes might be more deadly for women than men, at least when it comes to heart troubles, new research showsHeart disease occurs an average of 15 years earlier in people with diabetes, and is their main cause of illness an death. In women, the connection between diabetes and heart disease is particularly strong…” Click here for full story.
Health.com: “Only about 5% of those diagnosed with diabetes have type 1, which is why it may seem like this version of the disease seems a little more mysterious than type 2 diabetes—and with good reason: No one knows quite how to prevent type 1 diabetes yet, according to the Centers for Disease Control and Prevention (CDC)…” Click here for full story.
Healio: “Insulin is needed less frequently and HbA1c is lowered more robustly when adults with type 2 diabetes do not delay combination therapy but begin treatment by taking sitagliptin and metformin together, according to findings published in Diabetic Medicine…” Click here for full story.
Medscape: “Oral semaglutide (Rybelsus, Novo Nordisk) lowered hemoglobin A1c more than empagliflozin (Jardiance, Boehringer Ingelheim/Lilly) in a recently published open-label, head-to-head comparison of the type 2 diabetes drugs…” Click here for full story.
STAT: “Veterans who survive the horrors of war or the other dangers of military service often die years later from a silent but deadly scourge: diabetic foot ulcers, open sores or lesions that typically start on the bottom of the foot…” Click here for full story.
Healio: “Adults who undergo bariatric surgery may be more likely to be readmitted to the hospital, have more trips to the ICU and have a higher rate of overall morbidity if they have an HbA1c of more than 7% before surgery, according to findings presented at ObesityWeek…” Click here for full story.
World Health Organization: “The World Health Organization (WHO) today announced the start of a pilot programme to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries. The decision, announced ahead of World Diabetes Day (14 November), is part of a series of steps WHO will take to address the growing diabetes burden in all regions…” Click here for full story.
Medical News Today: “Doctors prescribe anti-inflammatory drugs long or short term to treat a range of conditions from allergies to arthritis. But could some of these drugs actually increase the risk for another chronic condition — diabetes?” Click here for full story.
NPR: “Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer’s disease. ‘There’s many reasons to get [blood sugar] under control,’ says David Holtzman, chairman of neurology at Washington University in St. Louis. ‘But this is certainly one…'” Click here for full story.
Healio: “The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA will vote today on whether to recommend approval of a supplemental new drug application for the SGLT2 inhibitor empagliflozin 2.5 mg as an oral medication adjunct to insulin therapy for adults with type 1 diabetes…” Click here for full story.
Science Daily: “Researchers have shown for the first time how a compound found only in avocados can inhibit cellular processes in the pancreas that normally lead to diabetes…” Click here for full story.
Healio: “In group medical visits for diabetes, adding intensive weight management with low-carbohydrate diets was as effective in improving blood sugar levels as conventional medication management, according to study results published in JAMA Internal Medicine…” Click here for full story.
USA Today: “Every time Mark Andrews jogs off the field between possessions in a game, he slips off his receiving gloves and pricks his finger. Then he does it again. And again. And maybe one more time, just to be sure…” Click here for full story.
Medscape: “The PREVIEW project is a multinational diabetes prevention project for which I was fortunate to be one of the principal investigators. It is funded by the European Union and includes six European countries plus Australia and New Zealand. We recruited 2300 people with proven prediabetes…” Click here for full story.
Phys.org: “Tufts University researchers have transplanted engineered pancreatic beta cells into diabetic mice, then caused the cells to produce more than two to three times the typical level of insulin by exposing them to light…” Click here for full story.
People: “As Diabetes Awareness month kicks off on Friday, Nick Jonas is opening up about living with type 1 diabetes. The 27-year-old Jonas Brothers member and solo artist shared a candid Instagram post on Friday to discuss how getting diagnosed with type 1 diabetes 14 years ago…” Click here for full story.
Medical News Today: “New research studies the association between environmental quality in over 3,000 United States counties and finds intriguing differences between rural and urban areas…” Click here for full story.
Medscape: “Cardiologists are well-placed to provide care for patients with type 2 diabetes, given their numbers and distribution relative to diabetes cases in the United States, new research suggests…” Click here for full story.
Healio: “Adults with type 2 diabetes are 55% more likely to sustain an incident vertebral fracture compared with adults without diabetes, with vertebral fracture history further raising the risk for experiencing a nonvertebral fracture, according to findings published in Diabetes Care…” Click here for full story.
Medscape: “For individuals who cannot or prefer not to take oral capsules, the same increase in vitamin D levels in the blood can be achieved with a sublingual spray, suggest the results of a small UK randomized controlled trial…” Click here for full story.
Science Daily: “Exercising before eating breakfast burns more fat, improves how the body responds to insulin and lowers people’s risk of type 2 diabetes and cardiovascular disease…” Click here for full story.
NPR: “At first, 19-year-old Sarah Hornak ignored the tingling in her hands and feet. She also ignored the 20 pounds of weight she shed, the constant hunger and thirst, the time she threw up after a tough workout. She went to her doctor only when she began to see halos everywhere…” Click here for full story.
ABC 12: “The parents of a 20-year-old East Carolina University student say a cure needs to be found after their son died from complications due to Type 1 diabetes…” Click here for full story.
Parkinsons News Today: “People with type 2 diabetes being treated with thiazolidinedione compounds, such as Actos (pioglitazone) and Avandia (rosiglitazone), may be at lower risk of Parkinson’s disease, a pilot study suggests. However, more work is needed to confirm a potential to prevent Parkinson’s in an at-risk patient population…” Click here for full story.
Naples News: “Nine experts in diabetes prevention and treatment, some from leading universities, will be in Naples for an annual diabetes program Sunday. The fifth annual von Arx Family Foundation Southwest Florida Diabetes & Wellness Conference helps families and medical professionals learn what’s new in the disease…” Click here for full story.
Healio: “Adults with diabetes have increased risks for infections, such as influenza, cellulitis and sepsis, compared with adults without diabetes, according to findings published in Diabetes Care…” Click here for full story.
Science Daily: “Limiting access to food in mice increases levels of the hormone, ghrelin, which may also increase motivation to exercise, according to a new study. The study suggests that a surge in levels of appetite-promoting hormone, ghrelin, after a period of fasting prompted mice to initiate voluntary exercise…” Click here for full story.
NPR: “Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer’s disease. ‘There’s many reasons to get [blood sugar] under control,’ says David Holtzman, chairman of neurology at Washington University in St. Louis. ‘But this is certainly one…'” Click here for full story.
Medscape: “The type 2 diabetes drug dapagliflozin (Farxiga, AstraZeneca) has been approved in the United States for reducing hospitalization for heart failure (HF) in adults with type 2 diabetes and other cardiovascular (CV) risk factors, the company has announced…” Click here for full story.
Medical News Today: “Scientists have highlighted a possible link between infection with rotavirus and an increased risk of developing type 1 diabetes. Undergoing vaccination against the pathogen may be an effective way to prevent the condition…” Click here for full story.
Channel 3000: “As Diabetes Awareness Month approaches in November, a Darlington student is raising money for a life-changing helper. High school senior Lexi Graham deals with diabetes every day. It’s been a part of her world for nearly eight years, and she knows how it changes everything…” Click here for full story.
Inside Carolina: “When Beau Corrales was in the seventh grade, he remembers sitting in the back of his classroom trying to read the projector, but it wasn’t as easy as it always had been. His vision began to get blurry, which was confusing because he had always had perfect eyesight. Then, in his first football game of the season, he went to the bathroom before kickoff just like normal. He continued to have to go after warm-ups and again before the start of the second quarter….” Click here for full story.
Healio: “Health care providers who treat patients with type 2 diabetes still need to include insulin among therapeutic options, and it may even be prudent to consider it earlier in the treatment process, according to a presenter at the Cardiometabolic Health Congress…” Click here for full story.
Medscape: “A new report from the Endocrine Society highlights the challenge of postprandial glucose management for people with insulin-requiring diabetes, providing some recommendations but also pointing out the major knowledge gaps…” Click here for full story.
Healio: “As the cost for insulin continues to rise, clinicians can take several proactive steps to help uninsured and underinsured patients afford their medications today, according to a speaker at the Cardiometabolic Health Congress…” Click here for full story.
NPR: “Nearly half of all children who develop Type 1 diabetes don’t know they have the disease until they end up in a coma in the hospital. Researchers in Virginia have set out to see if a genetic test for Type 1 diabetes can eliminate many of those emergencies…” Click here for full story.
Chicago Tribune: “A poor diet and lack of exercise can lead to diabetes. But your height could also be a factor, according to a new report. Researchers from the German Institute of Human Nutrition recently conducted a study, published in the Diabetologia journal, to determine the association between height and Type 2 diabetes risk…” Click here for full story.
The Courier: “Tessa McKenna can’t afford the $5,000 out-of-pocket deductible for the insulin that keeps her alive. A three-month supply of insulin — 10 vials — costs McKenna $2,700. ‘It’s really expensive…. The insurance that I’m on now is a high-deductible. It’s $5,000 for individual and $6,000 for family. Usually pharmacies want you to buy a three-month supply at a time,’ she said…” Click here for full story.
Good News Network: “When 18-year old Javier Larragoiti was told his father had been diagnosed with diabetes, the young man, who had just started studying chemical engineering at college in Mexico City, decided to dedicate his studies to finding a safe, sugar-alternative for his father…” Click here for full story.
Medscape: “Patients with newly diagnosed type 2 diabetes who had highly variable A1c levels between visits were more likely to have macro- and microvascular complications of diabetes in long-term follow-up, a study shows…” Click here for full story.
MedPage Today: “Certain racial and ethnic minorities, even at normal or below-normal body weight, were significantly more likely to have diabetes than whites, a large observational study demonstrated…” Click here for full story.
Science Daily: “Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required…” Click here for full story.
The New York Times: “A surprising new study challenged decades of nutrition advice and gave consumers the green light to eat more red and processed meat. But what the study didn’t say is that its lead author has past research ties to the meat and food industry…” Click here for full story.
Medical News Today: “While researchers already knew that drinks with added sugar could increase a person’s risk of type 2 diabetes, a new study suggests that the same may be true for naturally sweet drinks, such as 100% fruit juices, as well as artificially sweetened beverages, such as “diet” soft drinks…” Click here for full story.
WebMD: “British researchers have good news for people with type 2 diabetes — you don’t need to lose a ton of weight to make a difference in your health…” Click here for full story.
Healthline: “Fighting back against rising rates of type 2 diabetes and hypertension has been a losing battle for the medical community in the United States. Now, new research finds that adding fiber to your diet may help stave off these serious health conditions…” Click here for full story.
Medical Xpress: “Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required…” Click here for full story.
Healio: “The FDA approved a new indication for the SGLT2 inhibitor canagliflozin to reduce the risk for end-stage renal disease, worsening of kidney function, cardiovascular death and hospitalization for heart failure among adults with type 2 diabetes and diabetic kidney disease, according to a press release from Janssen…” Click here for full story.
Smart Brief: “The FDA has cleared Insulet’s Omnipod Dash alternate controller-enabled infusion pump as an integrated insulin pump. The system can hold up to 200 units of U-100 insulin and features a touch-screen personal diabetes manager for control of the pod…” Click here for full story.
Science Daily: “New research shows that a child’s intake of gluten at age 18 months is associated with a 46% increased risk of developing type 1 diabetes for each extra 10g of gluten consumed…” Click here for full story.
Medscape: “Worldwide, only a small proportion of adults with type 1 diabetes are achieving optimal glucose control, new research indicates. Findings from the multinational, observational Study of Adults’ Glycemia in TID (SAGE) were presented September 17 here at the European Association for the Study of Diabetes (EASD) 2019 Annual Meeting…” Click here for full story.
Refinery29: “Nick Jonas isn’t afraid to get real about his battle with type 1 diabetes. In an interview with Cigar Aficionado, he opened up about a close call he had when he was first diagnosed with the disease…” Click here for full story.
Time: “The conditions of human life began to improve with the Enlightenment of the 18th century, and we are better off now by many measures: food access, health, lifespan, and so on. But it hasn’t been an unbroken line of advancement…” Click here for full story.
CNN: “Taking antidepressants while pregnant may be associated with an increased risk of gestational diabetes, a new study suggests. It turned out that the increased risk appeared to be greatest for the two antidepressant drugs venlafaxine and amitriptyline, according to the study published in the journal BMJ Open on Tuesday. The study suggests a correlation but not causation…” Click here for full story.
healio: “Each 10 g of gluten consumed daily during infancy is associated with a 46% increased risk for developing type 1 diabetes during the next 12 years, whereas maternal gluten intake during pregnancy was not associated with future diabetes risk, according to study data presented at the European Association for the Study of Diabetes annual meeting.” Click here for the full story.
WebMD: “A new pill to lower blood sugar for people with type 2 diabetes was approved by the U.S. Food and Drug Administration on Friday.” Click here for the full story.
SciTech Daily: “In people with diabetes, fat mass index, not body mass index (BMI), is associated with a higher risk of cardiovascular events, according to new research in CMAJ (Canadian Medical Association Journal).” Click here for the full story.
Yahoo!: “New European research has found that individuals with low levels of vitamin D may have a higher risk of an early death, particularly if they have diabetes.” Click here for the full story.
Science Daily: “New research shows that specialist analysis of the lens in the eye can predict patients with type 2 diabetes and impaired glucose tolerance (IGT) (also known as prediabetes, a condition that often leads to full blown of type 2 diabetes).” Click here for full story.
FierceBiotech: “Two of the world’s largest companies in the diabetes space, Abbott and Sanofi, are partnering up to develop tools that integrate their respective blood sugar tracking and insulin delivery technologies. The end goal is to create a “connected device experience” for people managing their diabetes…” Click here for full story.
Healio: “Contrary to management guidelines, older adults with type 2 diabetes may overemphasize additional health conditions and complications when participating in decisions to enhance or de-intensify therapy, according to findings published in JAMA Internal Medicine.” Click here for full story.
Medical News Today: “A discovery in mice suggests a new opportunity for reducing the incidence of type 1 diabetes. Type 1 diabetes is on the rise. Scientists are not exactly sure why this is, but the increase in new cases makes the race to understand this life-threatening condition more urgent than ever.” Click here for full story.
BioSpace: “Medical device maker Medtronic and Novo Nordisk have entered a collaboration pact to develop ways of integrating insulin dosing management data from future Novo Nordisk smart insulin pens into Continuous Glucose Monitoring (CGM) devices from Medtronic.” Click here for full story.
Japan Today: “Shorter people are at greater risk of developing type 2 diabetes, according to a new study. Each additional 10 centimeters in height translates into a 41 percent smaller chance of contracting the disease in men and a 33 percent smaller chance in women, according to the research in medical journal Diabetologia.” Click here for full story.
Medscape: “Obese patients with type 2 diabetes who underwent bariatric (metabolic) surgery were less likely than similar patients who received medical treatment to experience one of six major adverse cardiovascular events (MACE), findings of a new observational study show.” Click here for full story.
ABC Denver: “Sometimes the best ideas are are born out of necessity. And in this case, a sixth-grader from Golden decided to do something when she saw a need for more pockets in her clothing. Sabrina Streich was diagnosed with Type 1 diabetes when she was 8 years old.” Click here for full story.
Healio: “Among a cohort of patients with type 2 diabetes who decided not to take insulin, the odds of achieving lower HbA1c measures were eight times higher for those who made adjustments to their lifestyle practices compared with those who did not, according to findings published in the Journal of Diabetes and its Complications.” Click here for full story.
Science Daily: “Scientists have discovered what may be the earliest possible biological marker of type 1 diabetes, formerly known as juvenile type 1 diabetes. If their mouse study can be replicated in humans, which they are now attempting to do, the timing of therapeutic intervention may be drastically improved for patients who are on course to develop the disease.” Click here for full story.
New Atlas: “New research from an international team of scientists has revealed the effects of a commonly prescribed type 2 diabetes drug are regulated by metabolites produced by certain gut bacteria.” Click here for full story.
Medscape: “The European Society of Cardiology (ESC) in collaboration with the European Association for the Study of Diabetes (EASD) has released new guidelines for the management and prevention of cardiovascular disease (CVD) in patients with diabetes or prediabetes.” Click here for full story.
Medscape: “A simple, low-cost automated text messaging program modestly improves glycemic control over usual care in patients with type 2 diabetes and coronary heart disease (CHD), a multicenter randomized trial carried out in China suggests.” Click here for full story.
The New York Times: “Every year, hundreds of thousands of obese Americans undergo weight-loss surgery in a last-ditch effort to shed pounds and control their Type 2 diabetes… Now a new study suggests that bariatric surgery may also have other significant health benefits, cutting the overall risk of serious cardiovascular events and premature death by almost half.” Click here for full story.
Labiotech.edu: “Under the motto #WeAreNotWaiting, DIYers around the world have developed more and more sophisticated tools that allow them to take control of their treatment. After glucose sensors, they moved on to hacking and controlling insulin.” Click here for full story.
Medical Xpress: “After a heart attack, patients with diabetes are at greater risk of heart failure and subsequent death than those without diabetes, according to late breaking results from the FAST-MI registry presented today at ESC Congress 2019 together with the World Congress of Cardiology.” Click here for full story.
Science Daily: “Research finds treatment for Post-Traumatic Stress Disorder (PTSD) that leads to an improvement in symptoms was associated with a 49 percent lower risk of incident type 2 diabetes.” Click here for full story.
Medical Xpress: “Researchers at Vanderbilt University Medical Center led by an assistant professor of Pediatrics have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with type 1 diabetes.” Click here for full story.
Medscape: “Roughly one in four adults with diabetes asked their physician for a cheaper prescription drug and 13% of patients took less medicine than prescribed to try to lower their drug costs, according to recent survey data.” Click here for full story.
Newsweek: “People with diabetes could be more likely to develop cancer because of how high blood sugar levels affect DNA, researchers believe.” Click here for full story.
Yahoo Finance: “Going off to college, while stressful for any student, poses risks to those with diabetes, according to a study in The Journal of the American Osteopathic Association.” Click here for full story.
Medical News Today: “People with diabetes, particularly those with type 1 diabetes, may have an increased risk of hypoglycemia (low blood sugar) if they receive too much glucose lowering therapy. New research now warns that many people with diabetes face that risk.” Click here for full story.
Science Daily: “For people with diabetes, taking medications and monitoring their blood sugar is part of the rhythm of their daily lives. However, according to new research, more than 20% of adult patients in the US are likely treated too intensively. This has caused thousands of potentially preventable emergency department visits and hospitalizations for hypoglycemia (low blood sugar).” Click here for full story.
Medscape: “Type 1 diabetes is frequently misdiagnosed in both children and adults, and misdiagnosis increases the risk for diabetic ketoacidosis (DKA) in children, new research finds.” Click here for full story.
Healio: “Health care providers must consider revising medication regimens when a person with diabetes adopts a ketogenic or other low-carbohydrate eating plan that can affect glucose levels and blood pressure, according to a speaker at the American Association of Diabetes Educators annual meeting.” Click here for full story.
Healthline: “Research continues to support the idea that reducing the amount of carbohydrates in your diet is a worthwhile goal for anyone with diabetes. Through the combined effort of Bispebjerg Hospital, Aarhus University, and the University of Copenhagen, researchers recently reported that a reduced-carbohydrate diet helped with both blood sugar levels and triglycerides in people with type 2 diabetes.” Click here for full story.
Grand Forks Herald: “Diabetes is an increasing challenge in North Dakota with the number of known people with diabetes growing in recent years… ‘I’ll say we’ve definitely noticed a steady increase in the need for services over decades,” said Sarah Howard, RN, BSN, diabetes educator with Trinity Health. “It goes back to 1994 and since then there has been a steady increase.'” Click here for full story.
Diabetes in Control: “Many health benefits have been associated with intermittent fasting including weight loss, reductions in blood sugar and insulin levels, and significant increases in the Human Growth Hormone (HGH): during intermittent fasting, HGH has shown to increase as much as five times over.” Click here for full story.
Kaiser Health News: “When Sam Mazaheri was 9, he was diagnosed with Type 1 diabetes. That means Sam’s body makes little or no insulin, a hormone that turns food into energy… ‘All of a sudden I had to manage everything he was going to take, including the insulin,’ said Sam’s mom, Nasim Mazaheri.” Click here for full story.
Medical News Today: “People with diabetes, particularly those with type 1 diabetes, may have an increased risk of hypoglycemia (low blood sugar) if they receive too much glucose lowering therapy. New research now warns that many people with diabetes face that risk.” Click here for full story.
Science Daily: “An injection has helped reduce body weight and glucose levels in patients with diabetes and obesity in four weeks.” Click here for full story.
Medscape: “Adding nuts to a regular diet significantly improves orgasmic function and sexual desire in healthy young men, according to the FERTINUTS study.” Click here for full story.
Healio: “In this video exclusive, Asha Brown, founder and executive director of We Are Diabetes, speaks with Endocrine Today Diabetes in Real Life columnist Susan Weiner, MS, RDN, CDE, FAADE, about eating disorders and how they manifest among people with type 1 diabetes.” Click here for full story.
Medical Xpress: “Few patients with undiagnosed prediabetes are told that they are at high risk for diabetes, according to a study published in the July issue of Clinical Diabetes.” Click here for full story.
Medscape: “There have been few improvements in diabetes diagnosis, linkage of patients to care, or achievement of treatment targets in the United States since 2005 despite advances in care, new research suggests.” Click here for full story.
Augusta Chronicle: “A surprising result of whole body vibration is a big increase in an uncommon bacteria and a large drop in inflammation in diabetic mice, which researchers at Medical College of Georgia are hoping to try in people.” Click here for full story. rel=”noopener”>Click here for full story.
Science Daily: “Patients with type 2 diabetes improve their ability to regulate blood sugar levels if they eat food with a reduced carbohydrate content and an increased share of protein and fat. The findings are contrary to the conventional dietary recommendations for type 2 diabetics.” Click here for full story.” rel=”noopener”>Click here for full story.
Healio: “Diabetes care is not a static endeavor. Health care providers and patients alike are inundated with new technology and information about how to best care for diabetes. For Jennifer A. LeBlanc, BSN, RN, CDE, director of professional education and care delivery at the Joslin Diabetes Center of Harvard Medical School in Boston, finding ways to simplify this process is crucial.” Click here for full story.” rel=”noopener”>Click here for full story.
The Guardian: “Thousands of people in England at risk of contracting type 2 diabetes will receive wearable tech to help monitor their exercise level, the NHS has said. Up to 8,000 people could benefit from the digital scheme designed to combat the disease, which has been spreading rapidly on the back of the obesity epidemic.” Click here for full story.
Medscape: “‘I feel fortunate to be alive. Despite aging and related stiffness, I feel wonderful.’ These are the words of Robert H. Eckel, MD, 71, who — when he takes over as co-president of the American Diabetes Association (ADA) in January — will bring unique credentials to the position: he has lived nearly his entire life with type 1 diabetes, while spending a 46-year career focused on heart disease in type 2 diabetes.” Click here for full story.
Healio: “Among men aged at least 70 years, type 2 diabetes appeared associated with a 35% reduction in risk for prostate cancer after consideration of standard risk factors, according to findings published in The Journal of Clinical Endocrinology & Metabolism.” Click here for full story.
Diabetes in Control: “Recent study results suggest that insulin pumps with CGM outperforms traditional monitoring in adolescents and young adults with type 1 diabetes for greater short-term outcomes.” Click here for full story.
Science Daily: “A new study, led by Professor Elina Hyppönen from UniSA’s Australian Centre for Precision Health, presents the strongest evidence yet of a causal relationship between obesity and a wide range of serious conditions, including cardiovascular disease, diabetes, cancer, and neurological, musculoskeletal and respiratory afflictions.” Click here for full story.
Medical Xpress: “In the face of diabetes, a common condition in which glucose and levels of destructive inflammation soar, whole body vibration appears to improve how well our body uses glucose as an energy source and adjust our microbiome and immune cells to deter inflammation, investigators report.” Click here for full story.
CNBC: “For the largest technology companies, there’s an opportunity in health care that’s too big to ignore. That’s to develop new tools and services for more than 100 million people living with diabetes or at high risk for the disease in the United States.” Click here for full story.
Medscape: “The epidemic of obesity, cardiovascular disease, and type 2 diabetes has prompted a call for a new internal medicine subspecialty: cardiometabolic medicine.” Click here for full story.
Medscape: “Use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors for the treatment of type 2 diabetes does not appear to increase the risk for urinary tract infections (UTIs) compared with two other new classes of type 2 diabetes agents, results from of a large population-based study indicate.” Click here for full story.
Science Daily: “A study that looked at data on more than 900,000 VA patients showed that elevated blood glucose levels detected in routine outpatient tests, though well below diagnostic thresholds, predicted diabetes within 5 years.” Click here for full story.
Healio: “Children with autism spectrum disorder appeared no more likely to have type 1 diabetes than children without the condition, although they may display some superior diabetes management outcomes, according to findings published in Diabetic Medicine.” Click here for full story.
Blueshirt Banter: “There are a lot of reasons to be excited about New York Rangers prospect Kaapo Kakko. After all, he has the potential to be the most exciting homegrown Ranger since Henrik Lundqvist and the most exciting homegrown Rangers forward since Rod Gilbert… Fans want to know all about the young Finn, including what life is like for him as someone who has both Type 1 diabetes and celiac disease.” Click here for full story.
Detroit Free Press: “Rachel Lockwood was on a mission when she drove more than 150 miles from Greenville to Detroit Sunday morning with three of her eight kids. She hopped on a bus to Windsor with U.S. Sen. Bernie Sanders, a Democratic candidate for president, with the goal of finding insulin in Canada at a fraction of the cost for what she pays for the drug in the United States.” Click here for full story.
The Wall Street Journal: “Diabetes patients are increasingly using electronic skin patches and their phones, instead of pricking their fingers, to do the complex job of managing a disease that affects more than 30 million Americans.” Click here for full story.
Medical News Today: “Scientists have yet to prove whether or not vitamin D can treat or slow type 2 diabetes. A new study of people who have recently received a diagnosis of diabetes or are at risk of developing it concludes that the vitamin may be beneficial.” Click here for full story.
Healio: “The FDA has approved several generic versions of pregabalin for the treatment of patients with neuropathic pain related to diabetic neuropathy, postherpetic neuralgia, partial onset seizures, fibromyalgia and spinal cord injury.” Click here for full story.
Science Daily: “A team scientists and physicians has identified a cellular connection between diabetes and one of its major complications — blood vessel narrowing that increases risks of several serious health conditions, including heart disease and stroke.” Click here for full story.
Yahoo Lifestyle: “Hemoglobin A1c is a widely accepted tool for monitoring glycemic control… It’s clear that HbA1c can be a very good indicator of control. I don’t think anyone can debate this. The problem is when it is used as the only indicator of control. How many of your clinicians rely solely on your HbA1c?” Click here for full story.
BuzzFeed News: “Sticking to a plant-based diet could help lower your risk of type 2 diabetes, a new paper suggests… That link between plant-based eating habits and type 2 diabetes is even more beneficial when only healthy plant-based foods…are included in your daily diet, as opposed to refined grains, starches and sugars, according to the study, published in the journal JAMA Internal Medicine on Monday.” Click here for full story.
CNN: “Sticking to a plant-based diet could help lower your risk of type 2 diabetes, a new paper suggests… That link between plant-based eating habits and type 2 diabetes is even more beneficial when only healthy plant-based foods…are included in your daily diet, as opposed to refined grains, starches and sugars, according to the study, published in the journal JAMA Internal Medicine on Monday.” Click here for full story.
Healio: “Fewer black and Hispanic adults with type 2 diabetes receive pharmaceutical treatment for depressive symptoms than their white peers, according to findings published in the Journal of Diabetes and its Complications.” Click here for full story.
Reuters: “British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with Type-1 diabetes.” Click here for full story.
Science Daily: “A new study demonstrates that just one hour of exposure to blue light at night — the kind of light produced by the screens of our many devices — raises blood sugar levels and increases sugar consumption in male rats.” Click here for full story.
Medscape: “Reducing daily food intake by the equivalent of just a couple of cookies, or around 300 calories, over 2 years leads not only to improvements in body composition but a range of cardiometabolic risk factors that could result in reductions in the incidence of cardiovascular disease, the results of an innovative study suggest.” Click here for full story.
Medscape: “Newly published results indicate that the injectable PCSK9 inhibitor alirocumab (Praluent, Sanofi/Regeneron) was more cost-effective in patients with a recent acute coronary syndrome (ACS) and uncontrolled ‘bad’ low-density lipoprotein cholesterol (LDL-C) (despite statins) if they also had diabetes.” Click here for full story.
Newsmax: “It is widely believed that people with “prediabetes” are on the fast track to developing type 2 diabetes. However, new research now suggests this is not necessarily true. In fact, in a majority of cases in a recent study prediabetes did not turn into diabetes.
Medscape: “Some people with type 2 diabetes who have made significant health progress since adopting a low carbohydrate diet should have their medications adjusted, according to guidance.” Click here for full story.
Fox 9: “After complications from diabetes caused him to lose his sight, a Minneapolis man has set out to warn others not to make the mistake he made — and has started a company to help with that mission.” Click here for full story.
Yahoo! Lifestyle: “Despite the fact that 100 million Americans now live with diabetes or pre-diabetes, the condition is still surrounded by confusion, misconceptions and flat-out wrong information. Part of the confusion surrounds the two different types of diabetes.” Click here for full story.
Diabetes In Control: “According to the American Diabetes Association, only 20% of patients with type 1 diabetes maintain the recommended A1C target of <7%… This has led to the investigation of SGLT inhibitors in type 1 diabetes, but recent study results raise serious concerns.” Click here for full story.
Medscape: “About a third of people who have lived with a diagnosis of type 1 diabetes for over 50 years still maintain detectable C-peptide production, and a small proportion have another form of diabetes that could signal their ability to come off insulin altogether, new research suggests.” Click here for full story.
Healio: “A cohort of low-income Latino adults with type 2 diabetes and food insecurity had higher insulin resistance than similar adults who were considered food-secure, with the association mediated by stress hormones, according to findings published in The Journal of Nutrition.” Click here for full story.
Science Daily: “Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver. Scientists have now discovered that mice on an intermittent fasting regimen also exhibited lower pancreatic fat.The researchers showed the mechanism by which pancreatic fat could contribute to the development of type 2 diabetes.” Click here for full story.
The New York Times: “The 8-year-old son of Caly and Wade Watkins is an active and happy Utah boy, they say. He fishes in a pond, sometimes landing a catfish, which he throws back. He rides his dirt bike for miles. He pores over his schoolwork, which in second grade included mastering multiplication tables. But at least four times a day, the Watkinses’s son, who has Type 1 diabetes, needs to test his blood sugar and take injections of insulin.” Click here for full story.
Medical News Today: “Depression and diabetes are two major causes of early death — particularly when they co-occur. Researchers have found that taking certain antidepressants may reduce mortality risk.” Click here for full story.
The Washington Post: “I still remember that stupid orange. I was 8 and in an intensive care unit. The nurse told me to practice sticking a syringe into the fruit.” Click here for full story.
StudyFinds: “Logging no more than seven to eight hours of work each day may be pivotal to women’s health. That’s because a recent study found that women who work more than 45 hours per week are at higher risk of developing diabetes compared to women who work less.” Click here for full story.
Reuters Health: “Older adults with slightly elevated blood sugar, sometimes called “prediabetes,” usually don’t develop full-blown diabetes, a Swedish study suggests.” Click here for full story.
Diabetes Research Foundation: “Continuous glucose monitoring (CGM) evaluations in islet transplant recipients who have been insulin independent for an average of 10 years show near-normal glycemic profiles and time-in-range metrics, according to data presented by the Diabetes Research Institute at the University of Miami Miller School of Medicine.” Click here for full story.
Medical News Today: “New research finds an elevated risk of type 2 diabetes among people who take statins in an effort to lower their cholesterol levels and keep heart disease at bay.” Click here for full story.
Healio: “Top-line results from the TIMES 3 study demonstrate the experimental oral diabetes drug imeglimin achieved its primary safety and efficacy endpoints, according to a press release from Poxel and Sumitomo Dainippon Pharma Co.” Click here for full story.
CBS News: “Medtronic is recalling several models of its MiniMed insulin pumps because of a cybersecurity risk that could allow hackers to take control of the devices remotely and change their settings, potentially leading to serious health complications.” Click here for full story.
Science Daily: “A new study suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially reversing the chronic inflammation and insulin resistance associated with obesity.” Click here for full story.
Reuters: “Family background can matter for the health of diabetic children, according to researchers in Denmark who found young patients’ blood sugar control was linked with the level of education their mothers had attained.” Click here for full story.
Medical News Today: “A new study from Ohio State University has found that a low carb diet can help those at a higher risk of developing diabetes — even if they do not actually lose any weight.” Click here for full story.
Medical News Today: “Apple’s health push now includes more tools for diabetics. Apple retail stores have started carrying a diabetes tracking product — in this case, One Drop’s blood glucose monitor. ” Click here for full story.
The New York Times: “At least four times a day, the Watkinses’s son, who has Type 1 diabetes, needs to test his blood sugar and take injections of insulin, including while in school. Last year, a disagreement over how his medical plan should be administered led the Jordan School District to bar the boy from attending classes, according to a lawsuit filed this month in Federal District Court.” Click here for full story.
Medscape: “The small yellow yard signs began to appear this spring, seemingly overnight and without fanfare. They’re peppered across the parking lots of shopping centers and along the stretch of U.S. Route 78 that runs through downtown Athens. ‘WE BUY DIABETIC TEST STRIPS,’ reads one sign.” Click here for full story.
The Washington Post: “As their minivan rolled north, they felt their nerves kick in — but they kept on driving. At the wheel: Lija Greenseid, a rule-abiding Minnesota mom steering her Mazda5 on a cross-border drug run. Her daughter, who is 13, has Type 1 diabetes and needs insulin. In the United States, it can cost hundreds of dollars per vial. In Canada, you can buy it without a prescription for a tenth of that price.” Click here for full story.
Medical News Today: “Brazilian scientists conducted a study on mice and found that strength training can reduce liver fat and improve blood sugar levels in people with diabetes.” Click here for full story.
Greatist: “Milk is a must-have for topping off your morning cereal, making clouds in your coffee, or washing down a spoonful of peanut butter. But if you have diabetes, don’t forget that this traditional beverage also contains carbs, which can affect your blood sugar levels.” Click here for full story.
Healio: “For the first time in 2019, the ADA began recommending screening for liver fibrosis in patients with type 2 diabetes suspected of having nonalcoholic fatty liver disease.” Click here for full story.
The Star: “This year, the difference between American centre Jack Hughes, favoured to go No. 1 overall to the New Jersey Devils, and Finnish winger Kaapo Kakko, expected to go second to the New York Rangers, could be razor thin… There is one thing that sets Kakko apart. He was diagnosed with both type 1 diabetes and celiac disease.” Click here for full story.
Everyday Health: “Researchers hypothesized that stronger diabetes medications could restore beta cell function or lower glucose levels in those with prediabetes, but after 12 months of treatment and three months off, the benefits disappeared.” Click here for full story.
Medical News Today: “A recent study finds that targeting a specific protein within the fat cells of mice reverses type 2 diabetes. The results also show that the protein can prevent the disease from developing.” Click here for full story.
Science Daily: “Vaccinating babies against a virus that causes childhood ‘stomach flu’ greatly reduces their chance of getting so sick that they need hospital care, a new study shows. But the study also reveals a surprise: Getting fully vaccinated against rotavirus in the first months of life is associated with a lower risk of developing Type 1 diabetes later on.” Click here for full story.
Healio: “Patients with untreated moderate or severe obstructive sleep apnea were at higher risk for incident type 2 diabetes that was nonlinear along the continuum of apnea-hypopnea index, according to study results published in Chest.” Click here for full story.
Medscape: “New study results raise concern as to whether the cardiovascular (CV) benefits seen in trials of type 2 diabetes drug classes, such as the sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, extend to black and African American patients.” Click here for full story.
Medical News Today: “A large new study has examined the effects of vitamin D on a diverse group of adults and found no evidence that this supplement can prevent type 2 diabetes.” Click here for full story.
WebMD: “Children diagnosed with type 1 diabetes at an early age have slowed growth in brain areas linked to mild cognitive deficits, new research suggests. The study compared MRIs of the brain in kids with type 1 diabetes to age-matched children without the condition. Researchers also saw that areas of slower brain growth were associated with higher average blood sugar levels.” Click here for full story.
Science Daily: “The Centers for Disease Control and Prevention deemed exposure to perfluoroalkyl substances — a class of chemicals used in cookware, cleaning products and paint — a public health concern. But new research explores how exposure to PFAS may be linked to lower heart disease rates in diabetic adults.” Click here for full story.
Medscape: “Vitamin D3 supplementation in people at high risk of developing diabetes but who did not have vitamin D insufficiency does not reduce the chances of developing the disease compared with placebo, the new results of a randomized, placebo-controlled trial show.” Click here for full story.
MedPage Today: “Insulin degludec plus liraglutide (IDegLira) was more durable than insulin glargine (IGlar U100) in maintaining glycemic control in patients with uncontrolled type 2 diabetes on oral antidiabetic drugs, a researcher reported here.” Click here for full story.
Healio: “Having diabetes has long been known to increase the risk of certain pregnancy-related complications — risks that can often be minimized by optimizing blood glucose control. But according to a new study, one group is particularly hard-hit by complications during pregnancy and childbirth: teenagers.” Click here for full story.
Medscape: “The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in patients in the NewLira trial, while the effects disappeared 6 weeks after treatment stopped.” Click here for full story.
Healio: “Researchers linked consumption of vitamins B2 and B6 to a lower risk for type 2 diabetes, according to a study presented at Nutrition 2019. A second study, also presented at Nutrition 2019, indicated that the order in which food is eaten may influence the onset of diabetes.” Click here for full story.
Endocrinology Advisor: “A gluten-free diet was associated with lower insulin demand and lower glycated hemoglobin (HbA1c) in newly diagnosed nonceliac pediatric patients with type 1 diabetes (T1D), according to study results presented at the American Diabetes Association 79th Scientific Sessions, held June 7 to 11, 2019, in San Francisco, California.” Click here for full story.
Medscape: “Young people who were diagnosed with type 2 diabetes in their early teens had an ‘alarming’ high rate of diabetes-associated complications by the time they were in their mid-20s, according to new research.” Click here for full story.
EurekAlert: “People with undetected glucose disorders run a higher risk of both myocardial infarction and periodontitis, according to a study published in the journal Diabetes Care by researchers at Karolinska Institutet in Sweden. The results demonstrate the need of greater collaboration between dentistry and healthcare, say the researchers, and possibly of screening for diabetes at dental clinics.” Click here for full story.
WRBL.com: “The U.S. Centers for Disease Control and Prevention says Diabetes is the 7th leading cause of death in the United States and affects nearly 10 percent of the US population. The federal government supports important Diabetes Research at the National Institutes of Health—to the tune of $150-million a year. That funding will dry up unless Congress acts soon.” Click here for full story.
Science Daily: “Women who experience symptoms of depression are at risk of developing multiple chronic diseases, research led by The University of Queensland has found.” Click here for full story.
Healio: “Adults with type 2 diabetes may be able to improvements their cognitive abilities by incorporating a Mediterranean diet into their regular disease management regimens, according to findings published in Diabetes Care.” Click here for full story.
Medical News Today: “Type 2 diabetes can sometimes result in a loss of heart function. However, the results of a new study suggest this function may be recovered through high-intensity exercise.” Click here for full story.
Harvard Health Publishing: “Of the estimated 23 million people in the US who have been diagnosed with diabetes, more than 30% take daily insulin injections to control their blood sugar (glucose) levels. Chances are good that someone you know has been startled by the high cost of this medication.” Click here for full story.
WebMD: “It’s unclear why new cases of diabetes among U.S. adults are decreasing while obesity rates continue to climb, experts say. The number of new diabetes cases fell from 1.7 million in 2009 to 1.3 million in 2017, according to federal data released Tuesday, the Associated Press reported.” Click here for full story.
Yahoo Finance: “T1D Exchange today announced the official launch of the T1D Exchange Registry, an online longitudinal database of people living with type 1 diabetes (T1D). This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their T1D in order to help researchers develop more targeted and effective approaches to treating and living with the disease.” Click here for full story.
Diabetes.co.uk: “Scientists have discovered a rogue immune cell coined the X cell which may be behind the development of type 1 diabetes. U.S. scientists from Johns Hopkins Medicine and IBM Research say further studies are needed to confirm the discovery, but claim they have “strong evidence” it could be a driver for type 1 diabetes.” Click here for full story.
Healthline: “A new treatment option — Eylea, from Regeneron Pharmaceuticals — has just been approved by the Food and Drug Administration (FDA) to treat all stages of diabetic retinopathy.” Click here for full story.
Science Daily: “University of Otago researchers have discovered that high-intensity exercise can reduce or reverse the loss in heart function caused by type 2 diabetes. The study found that three months of high-intensity interval training (HIIT) improved heart function in adults with type 2 diabetes, without any change in medications or diet.” Click here for full story.
The Washington Post: “The number of new diabetes cases among U.S. adults keeps falling, even as obesity rates climb, and health officials aren’t sure why. New federal data released Tuesday found the number of new diabetes diagnoses fell to about 1.3 million in 2017, down from 1.7 million in 2009.” Click here for full story.
Healio: “A combination of cognitive behavioral therapy and consistent exercise can be used to effectively treat major depressive disorder and depressive symptoms in those with type 2 diabetes, even in rural and underserved areas, according to findings published in Diabetes Care.” Click here for full story.
Healio: “For most children and adults with type 1 diabetes, day-to-day disease management remains difficult despite improvements in insulin formulations and delivery and advancements in diabetes technologies during the past decade.” Click here for full story.
TuftsNow: “When Olaf, a four-year-old Siberian husky, was diagnosed with diabetes in February, there wasn’t anything his owners, Gina and Brian Dacey, wouldn’t do to help him. “We’ve had him since he was a few weeks old, and he’s really still just a baby,” Gina Dacey said.” Click here for full story.
WebMD: “It has long been known that lifestyle affects a person’s risk of developing type 2 diabetes. Now, researchers report that they have identified rare variants of four genes that may also play a part.” Click here for full story.
South China Morning Post: “IBM is banking on artificial intelligence (AI) and connected devices to find new ways to help people stay healthy, as the world copes with an ageing population and prevalent chronic diseases.” Click here for full story.
The Guardian: “Javier Larragoiti was 18 when his father was diagnosed with diabetes. The teenager had just started a degree in chemical engineering in Mexico City. So he dedicated his studies to a side project: creating an acceptable alternative to help his father and millions of Mexicans like him avoid sugar.” Click here for full story.
Medscape: “The U.S. Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced.” Click here for full story.
Science Daily: “A revolutionary new study using only materials derived from humans has revealed that insulin-producing beta cells can change their function in diabetes — and that this change may be reversible.” Click here for full story.
Technology Networks: “UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes… The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.” Click here for full story.
Medical News Today: “Scientists have developed a way to increase the effectiveness of pancreatic islet transplantation, a promising therapy for type 1 diabetes. New findings could make pancreatic islet cell transplants more effective.
Immune rejection by the recipient is a major barrier to pancreatic islet transplants from donors becoming routinely available for the treatment of type 1 diabetes.” Click here for full story.
LA Times: “The U.S. Food and Drug Administration warned diabetics against building their own artificial pancreas system to help control blood sugar levels after a patient using one suffered an accidental insulin overdose.” Click here for full story.
MedPage Today: “Among U.S. adults at high risk for type 2 diabetes, participation in prevention programs was “exceedingly low,” according to authors of a large, population-based survey study… Additionally, healthcare professionals commonly failed to refer high-risk individuals to such programs or to advise lifestyle modifications to prevent diabetes, researchers led by Mohammed Ali, MD, of the CDC’s National Center for Chronic Disease Prevention and Health Promotion in Atlanta, reported online in JAMA Network Open.” Click here for full story.
Healio: “Motorists with diabetic peripheral neuropathy drive at slower speeds and are at increased risk for losing control of the vehicle compared with adults without peripheral nerve dysfunction; however, these drivers can improve with practice, according to results of a study conducted in the United Kingdom.” Click here for full story.
Science Daily: “Researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory. By targeting the protein and adding a physical enrichment method, the purity of beta cells improved from 30 to 80%. Improved control over the beta cell production process will allow researchers to refine cell therapy for patients with type 1 diabetes.” Click here for full story.
Medical News Today: “Using simple, routine measures that are easy to obtain in a diabetes clinic, such as age at diagnosis and body mass index, can be an effective way to choose the best treatment for a person with type 2 diabetes.” Click here for full story.
Healio: “Nearly 5% of adults with type 2 diabetes and obesity may have obstructive sleep apnea, which is more prevalent among those with obesity regardless of diabetes status compared with the general population, according to findings published in Diabetic Medicine.” Click here for full story.
Medical News Today: “Previous research has suggested a link between the presence of diabetes and a person’s risk of cancer. Now, a large study in a Chinese population shows that type 2 diabetes is associated with an increased risk of cancer — though females and males seem to be more at risk of different forms.” Click here for full story.
Diabetes in Control: “Late-onset type 1 diabetes can be difficult to identify… This study aimed to determine the prevalence and characteristics of type 1 diabetes defined by severe endogenous insulin deficiency after age 30 and assess whether these individuals are identified and managed as having type 1 diabetes in clinical practice.” Click here for full story.
AstraZeneca: “The U.S. Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to diet and exercise to improve glycaemic control in adults with type-2 diabetes (T2D).” Click here for full story.
Science Daily: “Many in-development cures for type 1 diabetes have understandably focused on tackling the autoimmune aspect of the disease before figuring out a way to replace the destroyed beta cells. But what if focusing on the beta cells first could prevent their destruction altogether? Researchers have found that increasing the proliferation and turnover of beta cells before signs of type 1 diabetes could halt the development of the disease.” Click here for full story.
Medical News Today: “Using simple, routine measures that are easy to obtain in a diabetes clinic, such as age at diagnosis and body mass index, can be an effective way to choose the best treatment for a person with type 2 diabetes.” Click here for full story.
Bustle: “A new insulin assistance program aimed at easing rising insulin costs passed the Minnesota House floor late last month. The Alec Smith Emergency Insulin Act, named after the 26-year-old Minnesotan who died from lack of insulin after aging off of his mother’s insurance, would create an emergency supply to help diabetics afford their insulin. The House passed the bill on April 25 as part of its health and human services omnibus bill.” Click here for full story.
AOL.com: “Viola Davis has chosen to live a life of significance. The Oscar-winning actress recognizes the immense privilege that comes with being as celebrated of an artist that she has become and, as she told AOL’s Gibson Johns during a recent sit-down interview during the Tribeca Film Festival, she sees that privilege as coming with an important responsibility to pay it forward.” Click here for full story.
Bustle: “According to a new study, intensive treatment for high blood pressure may reduce the risk of death from any cause, including cardiovascular disease, in people with type 2 diabetes.” Click here for full story.
Bustle: “A group of European researchers revealed the conclusions of their study into migraines the the end of 2018, and there were some surprisingly positive insights. At the end of their studies, the researchers concluded that they ‘observed a lower risk of developing type two diabetes for women with active migraine and a decrease in active migraine prevalence prior to diabetes diagnosis.'” Click here for full story.
Science Daily: “By restricting the time period during which they could eat, researchers have seen promising results for controlling blood glucose levels in men at risk of type 2 diabetes. In a small study, researchers assessed the effects of time-restricted eating (TRE) in 15 men for one week.” Click here for full story.
Medpage Today: “Hydroxychloroquine (HCQ, Plaquenil) might be a candidate as adjunctive therapy in type 2 diabetes, researchers reported here. Among adults patients with uncontrolled type 2 diabetes already on vildagliptin (Galvus, Zomelis) and metformin, HCQ significantly reduced HbA1c compared with baseline after 24 weeks (8.32% vs 7.11%, P=0.001), according to Amit Gupta, MD, of the G.D. Diabetes Institute in Kolkata, India, and colleagues.” Click here for full story.
Politifact: “If elected president, Democratic congressman Tim Ryan says he’d focus on a health care system that not only covers people when they are sick, but also keeps them healthy… ‘Half the country today has either diabetes or prediabetes,’ Ryan, a U.S. representative from Ohio, said at an April 11 WMUR town hall in Manchester. ‘A diabetic costs 2.3 times as much as every other patient. That is going to sink the health care system.'” Click here for full story.
Medical Xpress: “Indian women are younger and leaner than Swedish women when they develop gestational diabetes, a new study from Lund University shows. The researchers also found a gene that increases the risk of gestational diabetes in Swedish women, but which, on the contrary, turned out to have a protective effect in Indian women.” Click here for full story.
Medical News Today: “New research shows that people who follow a keto diet to lose weight or treat diabetes should avoid sudden spikes in blood sugar levels… One day may not make a big difference in the long-term, but a recent study from the University of British Columbia in Okanagan, Canada (UBCO), found that when it comes to the keto diet, a single dose of carbohydrates may have dangerous side effects.” Click here for full story.
Healio: “Nearly 30% of adults with type 2 diabetes may not take all their medications as instructed, including nearly one-quarter of those prescribed statins, according to findings presented in Diabetes Care.” Click here for full story.
Medical Express: “Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md… Study coauthor Jane Lynch, M.D., FAAP, professor of pediatrics at UT Health San Antonio, said the drug, liraglutide, in combination with an existing medication, metformin, showed robust effect in treating children studied in the Ellipse trial.” Click here for full story.
Medscape: “Metformin is associated with worse cognitive function in older adults, which could be explained by B-vitamin deficiency, new research suggests. ‘Fortified foods can provide a bioavailable source of B-vitamins and may be beneficial for maintaining better cognitive health in older people with or at risk for diabetes, but this requires confirmation in an intervention trial,’ Dr. Kirsty M. Porter of Ulster University in Coleraine, Northern Ireland, and colleagues conclude.” Click here for full story.
Science Daily: “A diet rich in animal protein and meat in particular is not good for the health, a new study finds, providing further backing for earlier research evidence. Men who favored animal protein over plant-based protein in their diet had a greater risk of death in a 20-year follow-up than men whose diet was more balanced in terms of their sources of protein.” Click here for full story.
Science Daily: “The increased risk of cardiovascular disease (CVD) upon developing type 2 diabetes is similar in men and women, show data from a large UK-based study of newly diagnosed patients.” Click here for full story.
Medscape: “The increased risk of cardiovascular disease (CVD) upon developing type 2 diabetes is similar in men and women, show data from a large UK-based study of newly diagnosed patients.” Click here for full story.
Innovation & Tech Today: “Thankfully, new technologies are making both types of diabetes easier to manage and less expensive to treat for both patients and medical professionals. “Diabetes is arguably the chronic condition most ripe for technological disruption,” says Dr. David Ahn, Endocrinologist and Program Director at the Mary and Dick Allen Diabetes Center in Newport Beach, California.” Click here for full story.
Medical News Today: “A new study shows that cheese improved insulin sensitivity in prediabetic rats, but industry funded the research… A recent study adds fuel to the fire by showing that both regular-fat and low-fat cheese improve insulin sensitivity in prediabetic rats. Dairy Farmers of Canada funded the study.” Click here for full story.
Endocrinology Advisor: “Metformin might improve whole-body and peripheral insulin sensitivity in overweight/obese adolescents with type 1 diabetes (T1D), according to study results published in The Journal of Clinical Endocrinology & Metabolism.” Click here for full story.
APNews: “A drug that’s used to help control blood sugar in people with diabetes has now been shown to help prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive.” Click here for full story.
Science Daily: “While some cereals may be the breakfast of champions, a professor suggests people with Type 2 Diabetes (T2D) should be reaching for something else. New research shows that a high-fat, low-carb breakfast (LCBF) can help those with T2D control blood sugar levels throughout the day.” Click here for full story.
The New York Times: “In older patients, rigorous lowering of blood sugar may offer few benefits and pose unexpected risks.” Click here for full story.
The Health Site: “You can give birth to a healthy baby and reduce his risk of developing diabetes by managing your eating habits during gestational diabetes. Here, we tell you foods you can eat when you experience a surge in your blood glucose levels during pregnancy.” Click here for full story.
Science Daily: “A new study comparing people with diabetes, prediabetes and normal blood sugar finds that diabetes, left untreated, could mean a higher likelihood of developing dementia, including Alzheimer’s disease.” Click here for full story.
Medical News Today: “In recent years, the ketogenic diet has become increasingly popular with people who want to lose weight quickly. A new study asks whether this dietary pattern works as well in females as it does in males.” Click here for full story.
USA Today: “The escalating cost of insulin has desperate diabetics rationing medication, acquiring the drug from friends or getting it from Canada or Mexico.” Click here for full story.
Reuters: “Women with pregnancy-related diabetes are at higher risk for developing cardiovascular disease in the decade after childbirth, a research review suggests.” Click here for full story.
WebMD: “A commonly used diabetes test may not spot the disease as well as an older test does, a new study suggests. The researchers said the newer test — called hemoglobin A1C — didn’t catch three-quarters of the diabetes diagnoses found by the older test — called an oral glucose tolerance test.” Click here for full story.
Reuters: “British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.” Click here for full story.
Medical Xpress: “Caucasians and Hispanics with diabetes have a greater risk of fracture compared to those without diabetes, while African Americans with diabetes have little to no additional fracture risk, according to a study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.” Click here for full story.
Technology Networks: “Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to a Clinical Practice Guideline issued today by the Endocrine Society. The Society debuted the guideline during a press conference on the opening day of ENDO 2019, its annual meeting in New Orleans, La.” Click here for full story.
A Sweet Life: “The FDA has denied approval of Sanofi and Lexicon’s drug, sotagliflozin, as an add-on to insulin therapy in the treatment of Type 1 diabetes. This decision comes just a few months after an FDA advisory panel failed to reach a consensus over whether the drug’s benefits outweigh its risks.” Click here for full story.
Healio: “Adults with type 2 diabetes may be able to achieve improved HbA1c levels and reduce depressive and distress symptoms when treated with personalized cognitive behavioral therapy, according to findings published in Diabetes Care.” Click here for full story.
Science Daily: “A new review featuring in the European Journal of Endocrinology suggests that a stressful work environment may increase the risk of developing type 2 diabetes in women.” Click here for full story.
Medical News Today: “In combination with conventional statistical methods, artificial intelligence (AI) has now been used in a study of risk factors in type 1 diabetes. The objective was to identify the most important indicators of elevated risk for cardiovascular disease and death.” Click here for full story.
Medical News Today: “Many people worldwide have type 2 diabetes, a metabolic condition in which the body cannot properly regulate blood sugar levels. Experts already know that lack of physical activity can contribute to the risk of diabetes, but what type of exercise might lower it?” Click here for full story.
NBC DFW: “Most people with diabetes have Type 2 diabetes, with an assortment of drugs at their disposal. But somewhere between 1.5 and 3 million Americans are living with Type 1 diabetes and their only drug option, insulin, is what keeps them alive. Now, in a world’s first, a new oral drug for this disease could change the way they manage their disease.” Click here for full story.
Healio: “Consuming red raspberries with breakfast could improve glycemic control in adults with overweight or obesity as well as prediabetes and insulin resistance, according to findings published in Obesity.” Click here for full story.
Science Daily: “People with diabetes who quit smoking tobacco may have a lower risk of heart attacks, strokes and other cardiovascular diseases — and weight gain following smoking cessation does not mitigate the health benefits among these patients, according to one study. Long-term, heavy smoking is a risk factor for cognitive decline, researchers found in an unrelated study.” Click here for full story.
Medical Xpress: “Factors that influence the health of our blood vessels, such as smoking, high blood and pulse pressures, obesity and diabetes, are linked to less healthy brains, according to research published in the European Heart Journal today.” Click here for full story.
Science Daily: “Diabetes is associated with various health problems including decline in skeletal muscle mass. A research group revealed that elevation of blood sugar levels leads to muscle atrophy and that two proteins play key roles in this phenomenon.” Click here for full story.
The New York Times: “More than 30 million people in the United States have diabetes. The vast majority of them have Type 2 diabetes. Some of those are testing their blood sugar at home, but the best research is telling us that they don’t need to — that in fact it’s a waste of money.” Click here for full story.
Fortune: “In an update to its genetic test, 23andMe is trying to make it easier for people to combat type 2 diabetes. When customers now purchase the company’s $199 Health & Ancestry Service test, they’ll get their saliva screened for type 2 diabetes, among a variety of other health conditions, the company said in a statement on Sunday.” Click here for full story.
Diabetes.co.uk: “Vitamin C supplementation is associated with improved blood glucose levels in people with type 2 diabetes, research suggests. A small Australian study, published in the journal Diabetes, Obesity and Metabolism, reports that people with type 2 diabetes who took a vitamin C tablet two times a day reduced their blood glucose spikes after meals by 36%.” Click here for full story.
Medscape: “Interval training may result in greater weight loss than continuous exercise, with sprint interval training (SIT) the most effective, say researchers, who say interval training also may be easier for obese and older individuals to perform.” Click here for full story.
WebMD: “The American Diabetes Association (ADA) state that eggs are a suitable food for people with diabetes. Having a low glycemic index score means that they have less of an effect on a person’s blood sugar levels.” Click here for full story.
Medical News Today: “The American Diabetes Association (ADA) state that eggs are a suitable food for people with diabetes. Having a low glycemic index score means that they have less of an effect on a person’s blood sugar levels.” Click here for full story.
Medical Daily: “When you are diagnosed with diabetes, you are more likely to experience various foot problems. There is also a much higher risk of complications — such as an amputation — compared to the rest of the population. Here are some problems you should get treated as soon as possible.” Click here for full story.
Medical Xpress: “Transplanting pancreatic islet cells into patients with diabetes is a promising alternative to the daily insulin injections that many of these patients now require. These cells could act as a bioartificial pancreas, monitoring blood glucose levels and secreting insulin when needed.” Click here for full story.
Express.co.uk: “Type 2 diabetes can be controlled by eating the right kind of diet, but it can be difficult to follow a strict diet when eating out. If you have diabetes, these are the best menu choices to prevent high blood sugar when dining at a restaurant.” Click here for full story.
Science Daily: “People with diabetes have a 35 percent higher risk of experiencing low back pain and 24 percent higher risk of having neck pain than those without diabetes, researchers have found.” Click here for full story.
Healio: “Improved mortality rates and decreases in CVD among patients with type 2 diabetes were associated with a higher consumption of nuts, particularly tree nuts, according to data published in Circulation Research.” Click here for full story.
Science Daily: “Traditional cell biology textbooks say that most cells can only differentiate to the same cell type, with the same function. It seems that some of these textbooks need to be rewritten, thanks to the new results by researchers at the University of Bergen and their international partners at Université de Genève (UNIGE), Harvard Medical School, Universiteit Leiden and the Oregon Stem Cell Center (OHSU).” Click here for full story.
WTOP: “During pregnancy the body goes through many changes and requires more insulin, which helps with control of blood sugar levels. Such changes sometimes leave a woman vulnerable to developing gestational diabetes — a type of the disease that occurs only during pregnancy.” Click here for full story.
KTNV: “Finding affordable daycare in Las Vegas is a difficult task for any parent, but a local mother says things got even harder when businesses learned her son has Type 1 diabetes.” Click here for full story.
Medscape: “Having type 1 diabetes per se may not affect school performance among children but glycemic control could, a Danish study suggests. ‘In this population-based cohort study, there was no statistically significant difference in pooled reading and math test scores between children with and without diabetes,’ note Niels Skipper, PhD, of the Department of Economics and Business Economics, Aarhus University, Denmark, and colleagues, in their article published online February 5 in JAMA.” Click here for full story.
Science Daily: “The benefits of vitamin D in promoting bone health are already well known. A new study suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.” Click here for full story.
Medical Xpress: “Just because it’s legal, doesn’t mean it’s safe. Exposure to cannabis — and, specifically, to THC — while in utero leads to heart defects and metabolic limitations likely to result in heart disease and diabetes later in life, according to a Western-led study.” Click here for full story.
Reuters: “People with diabetes who take soluble fiber supplements have slightly lower blood sugar than diabetics who don’t add this type of fiber to their diets, a research review finds… To examine the connection between viscous fiber supplements and blood sugar, researchers examined data from 28 clinical trials with a total of 1,394 participants with diabetes.” Click here for full story.
Medscape: “Only about one in five people with type 1 diabetes in the United States is achieving optimal glycemic control despite increased use of technologies such as insulin pumps and continuous glucose monitors (CGMs), new data show.” Click here for full story.
Healio: “Among insulin-naive adults with Type 2 diabetes, treatment with a high dose of oral insulin for 8 weeks lowered fasting plasma glucose at a rate comparable with participants assigned to insulin glargine, with no serious adverse events and a low incidence of hypoglycemia, according to findings from a phase 2 study.” Click here for full story.
PRNewswire: “Older adults go to the emergency department more often than other age groups, stay longer, and typically require more resources and medical interventions. The most common conditions among geriatric frequent users include diabetes, heart disease, kidney disease, congestive heart failure and blockage or damage to veins or arteries, according to new research in Annals of Emergency Medicine.” Click here for full story.
Science Daily: “It has been said that a good personality can help one succeed in life. But can it also guard against disease risk? A new study shows that positive personality traits, such as optimism, actually may help to reduce the risk of developing Type 2 diabetes.” Click here for full story.
Veg News: “Norma Wheelock has been confined to a wheelchair for 39 years, ever since being diagnosed with muscular dystrophy (MD). And so when she was given the additional diagnosis of Type 2 diabetes — a difficult diagnosis for anyone, but a devastating one for someone confined to a chair — Wheelock felt utter despair… It was her daughter and primary caretaker, Jennifer Wheelock, who started to research natural healing approaches to diabetes.” Click here for full story.
Healio: “The number of new cases of type 1 diabetes among young Australian children declined after oral rotavirus vaccination was added to the routine immunization schedule for children aged 6 weeks and older, according to research published in JAMA Pediatrics.” Click here for full story.
Science Daily: “You’ve probably heard that things like staying active, eating healthy and keeping your blood pressure in check can help your heart, and a new study finds that following a set of seven lifestyle factors can also drastically reduce your risk of developing diabetes.” Click here for full story.
MD Magazine: “Taking statins may help stave off retinopathy in patients with diabetes, according to a study. Signs and symptoms of diabetic retinopathy — the leading cause of vision loss in persons aged 20 to 74 years — are prevalent in about one-third of patients with type 2 diabetes (T2D), according to a 2015 study. Investigators estimate this rate will likely rise in the following years.” Click here for full story.
Medscape: “UK researchers have shown that in patients with type 1 diabetes who have well-trained medical alert “diabetes” dogs, the animals have greater sensitivity to changes in blood glucose than has been shown in previous studies.” Click here for full story.
Health24: “Rotating night-shift work together with an unhealthy lifestyle significantly increases the risk of type 2 diabetes, researchers say. ‘Most cases of type 2 diabetes could be prevented by adherence to a healthy lifestyle, and the benefits could be larger in rotating night-shift workers,’ said study authors led by Zhilei Shan” Click here for full story.
MedPage Today: “Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large cohort study from Taiwan. Statin therapy was also associated with a lower need for invasive treatments for vision-threatening diabetic retinopathy, and the benefits of statin treatment were dose dependent.” Click here for full story.
Science Daily: “Observational studies and clinical trials conducted over nearly 40 years reveal the health benefits of eating at least 25g to 29g or more of dietary fiber a day, according to a series of systematic reviews and meta-analyses.” Click here for full story.
ASweetLife: “With an increasing number of states legalizing marijuana for recreational use, and a large number of states allowing medical marijuana, and last year’s FDA approval of first cannabis-derived prescription drug, it’s not surprise people with diabetes have been asking about marijuana. Can it be used safely by people with diabetes and can it be used as a treatment for diabetes?” Click here for full story.
WebMD: “Drinking diet soda may raise the risk for a severe type of diabetic eye disease that can lead to blindness, a new study says. The study, published in Clinical and Experimental Ophthalmology, is the first to evaluate the link between soft drinks and what’s called proliferative diabetic retinopathy.” Click here for full story.
Science Daily: “Consumption of one egg every day seems to associate with a blood metabolite profile that is related to a lower risk of type 2 diabetes, a new study conducted in the University of Eastern Finland shows. The findings were published in Molecular Nutrition and Food Research.” Click here for full story.
Medscape: “Drinking diet soda may increase the risk for proliferative diabetic retinopathy — a severe type of diabetic eye disease that can lead to blindness — according to a study published online in the September/October issue of Clinical and Experimental Ophthalmology.” Click here for full story.
WebMD: “If you have type 2 diabetes and you’re taking canagliflozin to help control your blood sugar, a new study has some good news for you: The drug doesn’t appear to raise the risk of bone fractures.” Click here for full story.
Medical Xpress: “In collaboration with other international researchers, researchers at the University of Bergen have, discovered that glucagon-producing cells in the pancreas can change identity and adapt to do the job for their neighbouring damaged or missing insulin cells.” Click here for full story.
The Straits Times: “A recent international study found that drinking green tea was associated with an increased risk of type 2 diabetes in Chinese adults. A total of 119,373 participants from the Shanghai Women’s Health Study (SWHS) and Shanghai Men’s Health Study (SMHS) were included in the study.” Click here for full story.
Science Daily: “Using cutting-edge genetic analysis, the team was able to delve deeper than ever before into the complex correlations between diabetes and aspects including body weight.” Click here for full story.
EurekAlert: “Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat heart failure with preserved ejection fraction (HFpEF), a condition that is predicted to affect over 8% of people ages 65 or older by the year 2020.” Click here for full story.
ABC News: “Many people consider breakfast to be the most important meal of the day, and perhaps that’s for good reason. Skipping it might increase your type 2 diabetes risk, according to a new review of several studies.” Click here for full story.
Science Daily: “Lounging around all weekend may weigh heavy on the minds of the health conscious. But these sedentary stretches may not affect the waistline, provided they’re preceded by a bit of exercise. A new study from UT Southwestern Medical Center shows neurons in mice that influence metabolism are active for up to two days after a single workout.” Click here for full story.
WebMD: “Fasting before a cholesterol blood test is just a nuisance for most people, but for those with diabetes, it can be dangerous. New research shows that up to 22 percent of people with diabetes who fasted for lab tests had a low blood sugar episode (hypoglycemia) while waiting for the test.” Click here for full story.
Futurity: Research News: “For more than 29 million Americans with type 2 diabetes, testing their blood sugar is just part of daily life. But a new study suggests that some of them test more often than they need to.” Click here for full story.
Medical News Today: “Type 2 diabetes is a chronic condition that affects the body’s insulin production and blood sugar levels. New research, however, suggests that the scope of this condition may be broader than previously thought, as scientists find a link between type 2 diabetes and cognitive decline over 5 years.” Click here for full story.
Healio: “Women with active migraine were at lower risk for type 2 diabetes, according to findings recently published in JAMA Neurology. Researchers reviewed questionnaires from 76,403 women (mean age, 61 years) without type 2 diabetes that were part of a previously existing cohort in France… There was a lower risk for type 2 diabetes in women with active migraine vs. women with no migraine history.” Click here for full story.
Healio: “More than half of patients with type 2 diabetes being managed with treatments other than insulin who filled three or more claims for test strips may have used those supplies inappropriately, according to a report recently published in JAMA Internal Medicine.” Click here for full story.
Science Daily: “The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.” Click here for full story.
Forbes: “The legalization of recreational marijuana has dominated the news, recently, but medical marijuana research continues to advance apace… One of the most promising—and pressing—areas of research has to do with the effects of medical marijuana on people with diabetes. Millions of people suffering from the disease are looking for relief from both the symptoms and the high costs healthcare associated with treating the disease.” Click here for full story.
Medscape: “The glucose-lowering effects of the first-line treatment for Type 2 diabetes, metformin, have long been thought to be mediated through effects on liver cells, but new research suggests the drug may also significantly affect the gut microbiota and that this may independently contribute to glucose control.” Click here for full story.
Science Daily: “In the first ever international review of studies analyzing whether being an early riser or a night owl can influence your health, researchers have uncovered a growing body of evidence indicating an increased risk of ill health in people with an evening preference as they have more erratic eating patterns and consume more unhealthy foods.” Click here for full story.
Tech Crunch: “It can be tough for diabetes patients to keep a constant eye on their glucose levels. Spike Diabetes lets family and doctors lend a hand by sending them real-time alerts about the patient’s stats. And the app’s artificial intelligence features can even send helpful reminders or suggest the most diabetes-friendly meals when you walk into a restaurant.” Click here for full story.
Express: “Obesity accounts for at least 80 per cent of the risk of developing type 2 diabetes, said Diabetes.co.uk. It’s believed that abdominal fat causes fat cells to release chemicals that make the body less sensitive to insulin, it said. But, if you’re overweight, losing just a moderate amount of weight will help to lower your risk of diabetes.” Click here for full story.
Science Daily: “Cognitive difficulties in patients with diabetes, caused by repeated episodes of low blood sugar, could be reduced with antioxidants, according to a new study. The study findings suggest that stimulating antioxidant defenses in mice reduces cognitive impairments caused by low blood sugar, which could help to improve the quality of life for diabetic patients.” Click here for full story.
Pharmacy Times: “Recently, Purdue researchers developed a shoe insole that could help make the healing process more portable for the 15% of Americans who develop ulcers as a result of diabetes. The researchers used lasers to shape silicone-based rubber into insoles, and then create reservoirs that release oxygen only at the part of the foot where the ulcer is located.” Click here for full story.
Medical News Today: “A new review of existing studies published in The BMJ finds that sugary drinks that contain fructose raise the risk of type 2 diabetes more than other fructose-containing foods.” Click here for full story.
News Tribune: “By 2030, an estimated 79 million adults with Type 2 diabetes are expected to need insulin. But if current quantities of the medicine remain level, as many as 40 million sufferers could be left without it, according to a report in the journal The Lancet Diabetes and Endocrinology.” Click here for full story.
Medscape: “Working night shifts and having an unhealthy lifestyle appear to have an additive effect on the likelihood of developing type 2 diabetes, and women with both have a greater risk than simply adding the impact of either factor alone, suggests a pooled analysis of two major studies.” Click here for full story.
Medical News Today: “Previous research demonstrated that having psoriasis increases the risk of developing type 2 diabetes. A new study has tried to understand why this occurs.” Click here for full story.
Science Daily: “Following a Mediterranean diet low in calories and engaging daily physical activity have been demonstrated to result in reduce body weight and cardiovascular risk in overweight patients and patients with metabolic syndrome, and to maintain these benefits after one year.” Click here for full story.
Today Show: “Nick Jonas was diagnosed with Type 1 diabetes 13 years ago, and he’s sharing his struggle with the disease with his fans. In a post on Instagram, the singer showed side-by-side photos of himself from a few weeks after he was diagnosed to now.” Click here for full story.
EurekAlert: “A shoulder muscle that appears unusually bright on ultrasound may be a warning sign of diabetes, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).” Click here for full story.
Healio Endocrine Today: “Pennsylvania state legislators and diabetes advocates gathered at the statehouse recently to raise awareness about the rising incidence of type 1 diabetes in young children and the dangers that can accompany a missed diabetes diagnosis, including diabetic ketoacidosis.” Click here for full story.
Medical News Today: “According to new research, a hot bath could have effects that extend way beyond mental relaxation. According to the authors, regular hot baths might reduce inflammation and improve metabolism.” Click here for full story.
ABC News: “November is National Diabetes Month, but for the more than a million children and adults in the U.S. living with Type 1 diabetes, every day and night is a constant reminder of a physically and emotionally tedious disorder that requires constant monitoring.” Click here for full story.
Healthline: “Despite the number of diabetes treatment options available today, researchers are saying a significant number of patients with type 2 diabetes are not seeing any significant improvements in their blood sugar levels… Experts say people with type 2 diabetes need to be sent to specialists so they can get on proper treatment plans.” Click here for full story.
Healthy Hearing: “More than 30 million Americans have diabetes — if you’re one of them, take note. You may want to keep a close watch on your hearing, too. Research indicates diabetics are more than twice as likely to develop hearing loss than those without the disease.” Click here for full story.
HealthDay: “The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows. Type 2 diabetics who took Farxiga (dapagliflozin) saw their odds of hospitalization for heart failure drop by 27 percent compared to those who took a placebo, according to a study funded by the drug’s maker, Astra-Zeneca.” Click here for full story.
Science Daily: “A recent pilot study by kinesiologists found that pedaling while conducting work tasks improved insulin responses to a test meal. Investigators found that insulin levels following the meal were lower when sedentary workers used a pedal desk compared to a standard desk. In addition, work skills were not decreased in the pedaling condition.” Click here for full story.
Economic Times: “Women behave differently when affected by diabetes than men. Women tend to be further along in the disease when they are diagnosed, making them far more susceptible to complications.” Click here for full story.
Science Daily: “Eating Brazil nuts and other varieties of nuts daily may prevent weight gain and provide other cardiovascular benefits, according to two separate preliminary studies to be presented at the American Heart Association’s Scientific Sessions 2018 in Chicago, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.” Click here for full story.
Medical Xpress: “Being with someone who has diabetes and needs immediate care to avoid a coma can be a frightening situation. Even worse, current products and injection kits to help in those emergencies can be complicated to use. Now Purdue University researchers are working on a solution similar to common EpiPen devices that could help diabetic patients and others with hypoglycemia.” Click here for full story.
WebMD: “Diabetes is a formidable foe that can tax the bodies and the spirits of people diagnosed with the blood sugar disease. But a plant-based diet may help boost the physical and the mental health of unhappy people with type 2 diabetes, a new evidence review reports.” Click here for full story.
CNBC: “There is a revolution in the Type 1 diabetes community and thousands of people are now hacking their insulin pumps for better blood sugar management. CNBC’s Erin Black, who was diagnosed with Type 1 diabetes 20 years ago, decided to try out the hacked system. Here’s what happened.” Click here for full story.
Medical Xpress: “People who have had a colectomy have increased risk of developing type 2 diabetes, according to a new study by researchers from the University of Copenhagen and Bispebjerg and Frederiksberg Hospitals. The researchers hope their effort will pave the way to methods for preventing and treating the disease. The research results have just been published in the scientific journal eLife.” Click here for full story.
MedPage Today: “Diabetic patients treated with metformin had almost a 50% lower risk of developing age-related macular degeneration (AMD), a large retrospective study from Taiwan showed. Overall, metformin users had a 46% reduction in the relative risk of AMD, as compared with nonusers.” Click here for full story.
Science Daily: “Canadian and British researchers have discovered how the frontline Type 2 diabetes drug metformin may work to help cells better take up and use glucose. Their study, published today in the journal Cell, may also explain other potential beneficial effects of metformin for prevention of a variety of chronic diseases, including cancers.” Click here for full story.
MedPage Today: “Diabetic patients without retinopathy achieved 20/20 vision after cataract surgery as often as nondiabetic patients did, a retrospective analysis of a large community-based cohort showed.” Click here for full story.
Science Daily: “A study shows that the gut microbiota has the ability to affect how cells respond to insulin, and can thus contribute to type 2 diabetes. The findings demonstrate an hereto unknown pathological mechanism.” Click here for full story.
Medical News Today: “People with diabetes need to be aware of their carbohydrate intake. Although potatoes are a starchy vegetable, it is still possible for a person with diabetes to enjoy them as part of a healthful diet.” Click here for full story.
Science Daily: “An international collaboration has made a discovery that could make therapeutic insulins more effective by better mimicking the way insulin works in the body. The findings could improve treatments for diabetes, a disease that impacts the lives of millions of people worldwide.” Click here for full story.
Tyler Morning Telegraph: “Each year, people die or develop permanent diabetes complications because they skip or decrease doses of medication in order to save money. Many people are embarrassed to admit that they cannot afford their medications, but they should not be… Your health care team cannot help you explore options if they do not know a problem exists.” Click here for full story.
Rekord Centurion: “The Voortrekker Monument will be lit up in blue for the month of November to honour world diabetes day and all who suffer from the condition. World diabetes day (WDD) is a global awareness campaign focusing on diabetes awareness that is held annually on November 14, with the month of November being labelled diabetes awareness month.” Click here for full story.
Medscape: “Onset of type 1 diabetes after age 30 years is common and often misdiagnosed as type 2 diabetes in clinical practice, new data show. The findings were presented October 4 here at the European Association for the Study of Diabetes (EASD) 2018 Annual Meeting by Nicholas J. Thomas, MD of the University of Exeter, United Kingdom.” Click here for full story.
Medical News Today: “Lifestyle changes are key in the management of type 2 diabetes. Scientists believe that intermittent fasting could play an essential role… Researchers used intermittent fasting as a method to reduce the symptoms of type 2 diabetes in a new observational study conducted in Canada and published in the journal BMJ Case Reports.” Click here for full story.
ScienceDaily: “For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications. Researchers recently evaluated the accuracy of new technology to monitor blood glucose levels without needles or a finger prick. Early results show that the noninvasive technology measures blood glucose levels as effectively as a finger prick test — without drawing blood. ” Click here for full story.
Everyday Health: “New research suggests healthy levels of a hormone released during breastfeeding are linked with a reduced risk of diabetes in women, but researchers aren’t sure why this association exists and how the hormone may play a role in possibly preventing the disease.” Click here for full story.
Medical News Today: “Fatigue is a common symptom of diabetes and can result from high blood sugar levels and other symptoms and complications of the condition. Some lifestyle changes can help a person manage diabetes fatigue.” Click here for full story.
dLife.com: “If you have trouble getting on the treadmill, a new study — which finds that not exercising can be more detrimental for your health then smoking, having diabetes or heart disease — may convince you that it’s time to change your habits.” Click here for full story.
EndocrineWeb: “While doctors and researchers have long known that having type 1 diabetes increases the tendency to have urinary and sexual problems, information on how common and why has been lacking. A survey asking women and men with type 1 diabetes presents about these issues offers a clearer understanding of the impact of these critical life factors;1 the study appears in the journal, Diabetes Care.” Click here for full story.
Healio: “Compared with multiple daily insulin injections, inhaled insulin was shown to provide benefits for adults with type 1 diabetes, including improved postprandial glucose levels, lower daytime glucose variability and less hypoglycemia, according to a study published in Diabetes Technology & Therapeutics.” Click here for full story.
Medical Xpress: “Diabetes reduces the immune system’s ability to fight certain infections. This raises the risk for serious complications from diseases that vaccines protect against—including flu, pneumonia, hepatitis B, tetanus and shingles. ‘People with diabetes may be at higher risk of getting certain diseases and also serious problems from diseases that could’ve been prevented with vaccines,’ said Evan Sisson, an associate professor at Virginia Commonwealth University.” Click here for full story.
National Institutes of Health: “People with prediabetes or new-onset type 2 diabetes who had gastric banding, a type of bariatric surgery for weight loss, had similar stabilization of their disease to those who took metformin alone, according to a study supported by the National Institutes of Health. These findings were published on October 3 in Diabetes Care (link is external), coinciding with a presentation during the European Association for the Study of Diabetes Annual Meeting in Berlin.” Click here for full story.
ScienceDaily: “Russian tarragon and bitter melon supplements may be less helpful for women than men when it comes to combating metabolic syndrome, whose symptoms include high blood sugar, high blood pressure and excess fat around the waist, a new study suggests.” Click here for full story.
Everyday Health: “Could restricting your diet for a couple of days a week put type 2 diabetes in remission? That’s the controversial claim scientists of a small new study are making as they fan the fire around a diet fad known as intermittent fasting. But many health professionals, including those at the American Diabetes Association, argue that the approach can be dangerous for people with diabetes, whose bodies cannot control their blood sugar without careful diet, medication, and sometimes insulin management.” Click here for full story.
dLife.com: “Interviewing both teens and parents, Joslin Diabetes Center researchers have identified strategies to help teens with [cardiovascular] conditions manage them better, says Dr. Michelle Katz, lead author on a paper about the work recently published in Pediatric Diabetes.” Click here for full story.
Healio Endocrine Today: “Women diagnosed with gestational diabetes or preeclampsia are more likely to develop hot flashes during the menopause transition vs. women who are not diagnosed with those conditions, according to an analysis of the SWAN study presented at the North American Menopause Society annual meeting.” Click here for full story.
Medical News Today: “New research that set out to analyze the temperatures at which people living with diabetes store their insulin is now warning against the perils of improper storage for the quality and effectiveness of the hormone.” Click here for full story.
Medscape: “An investigational “hybrid closed-loop” insulin delivery system improved blood glucose control and reduced the risk for hypoglycemia among children and adults with suboptimally controlled type 1 diabetes.” Click here for full story.
Medical News Today: “A study that draws on data from more than 100,000 people finds a link between diabetes and an increased risk of osteoporosis, osteoarthritis, and rheumatoid arthritis.” Click here for full story.
Medical Xpress: “The number of Americans with diabetes who wind up in hospitals with serious infections, or who develop them while in the hospital, is on the rise. Between 2010 and 2015, the number of diabetics hospitalized for infections rose 52 percent…according to researchers from the U.S. Centers for Disease Control and Prevention.” Click here for full story.
Science Daily: “Early signs of type 2 diabetes can be identified more than 20 years before diagnosis, according to new research presented at this year’s European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, Germany (1-5 October).” Click here for full story.
Specialty Pharmacy Times: “Type 2 diabetes remains the most common type of diabetes diagnosed in American adults, but rates are increasing among both disease subtypes, according to a new study.” Click here for full story.
Healio: “The venture philanthropy organization JDRF T1D Fund is investing in ImmusanT, a clinical-stage company looking to develop a vaccine to prevent type 1 diabetes following on its peptide immunotherapy program for celiac disease, the two entities announced in a press release.” Click here for full story.
Science Daily: “A new study finds that perfluoroalkyl and polyfluoroalkyl substances (PFASs) are associated with increases in weight, but exercise and diet may reduce the obesogenic effects of these environmental contaminants.” Click here for full story.
Medscape: “Reports of patients using standard pen needles to inject insulin without removing the inner needle cover have prompted the US Food and Drug Administration (FDA) to issue a safety communication on proper use of pen needles.” Click here for full story.
Albany Herald: Blue Cross and Blue Shield of Georgia “has launched a ‘virtual’ diabetes clinic in partnership with Onduo, a Massachusetts-based diabetes management company. The program is free to most Blue Cross members who have work-based or individual insurance in Georgia, as part of a large pilot program.” Click here for full story.
Healio: “The prevalence of diabetes among adults in the United States rose to 14% between 2013 and 2016, with nearly 31% of those with diabetes unaware they have the disease, according to a new report from the CDC’s National Center for Health Statistics.” Click here for full story.
Science Daily: “Most patients with type 2 diabetes are treated with a ‘one-size-fits-all’ protocol, but this approach can leave many cases inadequately managed. New work indicates that inherited genetic changes may underlie the variability seen among diabetes patients, with different physiological processes potentially leading to high blood sugar. This work represents a first step toward using genetics to identify subtypes of type 2 diabetes.” Click here for full story.
Express.co.uk: “Type 2 diabetes is caused by having too much sugar in the blood. This doesn’t mean people with diabetes have to completely cut sugar from their diet, but it should be limited in order to keep blood glucose levels under control. So are sweeteners a suitable alternative?” Click here for full story.
CBS Los Angeles: “It now seems that gluten can affect more than just the person who eats it, reports Dr. Max Gomez. Danish scientists, after analyzing data from thousands of pregnant women, say a high gluten diet may put offspring at higher risk for type 1 diabetes.” Click here for full story.
Everyday Health: “Researchers don’t know the exact cause of type 1 diabetes, but new preliminary research suggests that a mother’s eating habits during pregnancy could play a role. The study, published online in September 2018 in BMJ, found that the more gluten a woman consumed during her pregnancy, the more likely her offspring was to develop type 1 diabetes.” Click here for full story.
Fortune: “Some news from the land of CRISPR gene-editing to start off this week: The appropriately named CRISPR Therapeutics…is partnering with San Diego-based ViaCyte in an effort to tackle type 1 diabetes.” Click here for full story.
Healio ITJ: “In adolescents, current physical activity level has a greater effect on metabolic health than time spent being sedentary, according to findings from a prospective cohort study published in PLOS Medicine. ” Click here for full story.
Science Daily: “In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study indicate that the Food and Drug Administration-approved ‘safe’ daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases.” Click here for full story.
Medical News Today: “The importance of sleep is well-known. A recent study enforces this by demonstrating that sleep deprivation might increase diabetes risk — after losing just 1 night of sleep.” Click here for full story.
Medical News Today: “Diabetes is a chronic condition that causes a person’s blood glucose levels to become too high. Although people with diabetes often need to carefully manage their diet, incorporating the occasional sweet or sugary food into a healthful diet can still be okay.” Click here for full story.
Longview News-Journal: “Hurricane Florence made landfall near Wilmington, North Carolina, with hurricane-force winds, catastrophic flooding and widespread power outages that will severely impact the Carolinas and the Appalachian Region. The Diabetes Disaster Response Coalition (DDRC)…has prepared multiple online resources to support all people with diabetes, especially those who depend upon insulin, so they can continue to effectively manage their diabetes.” Click here for full story.
Harvard Health: “With improved public education, it is now common knowledge that uncontrolled diabetes leads to damage to the major organs of the body, such as the heart, kidneys, eyes, nerves, blood vessels, and brain. So, it is important to ask how tightly blood glucose (also called blood sugar) should be controlled to decrease the risk of harm to these organs.” Click here for full story.
Medscape: “Lower vitamin D (25-hydroxyvitamin D) levels are found in patients with painful diabetic peripheral neuropathy (DPN) compared to those with painless DPN, patients with diabetes without any neuropathy, and healthy people, shows a study unique for its rigorous control for seasonal sunlight and physical activity.” Click here for full story.
Futurism: “In a study published on Monday in The Journal of Diabetes Science and Technology, researchers at University of Utah Health examine how the diabetes community uses Twitter to share information on open source artificial pancreas (OpenAPS) technology, a DIY hack of two diabetes management devices.” Click here for full story.
Healio: “Older adults with type 1 diabetes with prolonged exposure to HbA1c at least 8% are at least twice as likely to develop dementia over 6 years vs. similar adults with only 10% of measurements in the same range, according to findings published in Diabetes Care.” Click here for full story.
New York Post: “Eat your Wheaties to avoid diabetes. That’s the takeaway from a new study showing that whole-grain foods could be one of the easiest weapons against Type 2 diabetes, a condition that disrupts the body’s sugar metabolism and is one of the leading causes of death in the United States.” Click here for full story.
Employee Benefit News: “After reviewing several health plans that attempt to reduce the risk of Type 2 diabetes, [the Purdue University] benefits team partnered with Virta Health to provide online coaching to faculty and staff members. Virta Health aims to reverse the disease without the use of drugs or surgery, relying on virtual coaching to spur program participants into healthy habits.” Click here for full story. (Learn about supporting employees with diabetes in “Employees With Diabetes: A Supervisor’s Guide.”)
Science Daily: “A collagen formulation mixed with pancreatic cells is the first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days, a pre-clinical animal study shows.” Click here for full story.
WebMD: “A short stretch of inactivity can unleash diabetes in older adults at risk for the blood-sugar disease, a new study finds.” Click here for full story.
Science Daily: “One night of sleep loss has a tissue-specific impact on the regulation of gene expression and metabolism in humans, according to researchers. This may explain how shift work and chronic sleep loss impairs our metabolism and adversely affects our body composition.” Click here for full story.
Medical News Today: “Type 2 diabetes is a chronic condition that can develop at any age. It often has a slow, gradual onset, which can make it difficult to detect and diagnose in children. In this article, we look at what type 2 diabetes is and describe its symptoms, causes, and risk factors in children.” Click here for full story.
OKC Fox: “Ever wonder what it’s like to speed around a winding racetrack at 200 mph in a 130-degree car? Now consider doing that while managing a chronic health condition like Diabetes. NASCAR Xfinity Series Driver Ryan Reed and Racecar Driver Conor Daly know exactly what it’s is like. The two talk about how they balance their diabetes and their racing careers.” Click here for full story.
Deccan Chronicle: “Skipping breakfast is not advisable when it comes to maintaining a healthy diet for overall well being. But there are ways to make up for it and it’s as simple as getting your snacking habits right.” Click here for full story.
Science Daily: “New research finds that middle-aged men who sleep five hours or less per night have twice the risk of developing a major cardiovascular event during the following two decades than men who sleep seven to eight hours.” Click here for full story.
EndocrineWeb: “When it comes to diet, not everything about keeping your blood sugar down (or decreasing your risk of diabetes) has to be difficult. Canadian researchers have come up with a clever diet swap that’s both easy and gets great results in keeping down blood sugar.” Click here for full story.
Express.co.uk: “Making some small dietary changes could help to prevent the symptoms of high blood sugar. One of the best foods to add to your diabetes diet is eggs, a nutritionist has revealed.” Click here for full story.
Healio Endocrine Today: “Members of the diabetes online community identify judgment, education and health care teams as major themes related to stigma, according to findings presented at the American Association of Diabetes Educators annual meeting.” Click here for full story.
Atlanta Journal-Constitution: “A new study, published in the American Journal of Clinical Nutrition, found that each daily cup of non-cow’s milk was associated with 0.15 inches lower height than average.” Click here for full story.
Science Daily: “A change in breakfast routine may provide benefits for the management of type 2 diabetes, according to a new study. A team of scientists found that milk consumed with breakfast cereal reduced postprandial blood glucose concentration compared with water, and high dairy protein concentration reduced postprandial blood glucose concentration compared with normal dairy protein concentration.” Click here for full story.
Medical News Today: “A new study looks at how eating a common type of mushroom can affect glucose, or blood sugar, regulation. The results may have implications for managing diabetes and other metabolic conditions, such as obesity.” Click here for full story.
Practice Update: “Little excess risk of death is seen for patients with Type 2 diabetes with five risk-factor variables within target ranges, according to a study published in the Aug. 16 issue of the New England Journal of Medicine.” Click here for full story.
Medscape: “Type 2 diabetes rates among children and young people in England and Wales have continued to grow, latest figures show.” Click here for full story.
Endocrinology Advisor: “Bariatric surgery in type 2 diabetes (T2D) was associated with half the incidence of microvascular disease at 5 years, including a lower incidence of nephropathy and retinopathy, compared with medical care, according to findings published in the Annals of Internal Medicine.” Click here for full story.
Seeking Alpha: “Tandem Diabetes Care [has announced] the U.S. commercial launch of the t:slim X2 Insulin Pump with Basal-IQ technology, a low glucose suspend feature designed to reduce the frequency and duration of hypoglycemic (low blood sugar) events.” Click here for full story.
Science Daily: “A newly published study has identified a potential therapeutic target for treating obesity and diabetes. The scientists studied the biological function of an epigenetic modifier known as histone deacetylase 11 (HDAC11), and determined that deleting it in mice stimulates the formation of brown adipose tissue.” Click here for full story.
WebMD: “People with Type 1 diabetes have a much greater risk of serious heart problems and early death, especially if they were diagnosed before age 10, new research suggests.” Click here for full story.
Health24: “Working overtime at work and at home can be hazardous to women’s health.” Click here for full story.
Health Data Management: “Technology is offering new ways to help those with diabetes, or their loved ones, monitor the disease.” Click here for full story.
Healio: “Adults diagnosed with Type 1 diabetes before the age of 10 have a 30 times increased risk for heart disease and heart attack as young adults, according to new research in The Lancet.” Click here for full story.
Gulf Times: “A research project has led to the development of wearable devices that could improve the prevention, management, and treatment of diabetic foot ulcers.” Click here for full story.
The FDA has approved Abbott’s Freestyle Libre 14-Day Flash Glucose Monitoring System, to replace the current 10-day version, as reported by Medscape. The Libre is now the longest-lasting continuous glucose monitor (CGM) on the US market. Click here for full story.
A simple saliva sample could replace blood tests to assess and monitor diabetes, finds a new study outlined by Science Daily. The most comprehensive analysis of proteins in saliva to date finds that these proteins reflect high blood sugar and associated disease processes in children and adolescents with uncontrolled type 1 diabetes, long before the appearance of clinical symptoms. This could lead to better prediction and prevention of long-term complications of the disease. Click here for full story.
A new study from Stanford University School of Medicine shows that blood sugar levels in people without diabetes fluctuate more than they think. DLife reports that the researchers used continuous glucose monitoring devices instead of the traditional finger prick method to gather more accurate blood sugar levels. Click here for full story.
A study findings highlighted by Healio, revealed that blood glucose level was the only cardiometabolic factor with consistently elevated mean levels among patients with dementia compared with controls up to 14 years before diagnosis. Click here for full story.
Live Science reports, about eight years ago, Darkes said, doctors diagnosed him with type 1 diabetes, but early last year, routine finger-prick tests showed his blood-sugar levels were normal, so doctors advised him to stop his insulin injections. Click here for full story.
The diagnosis from Anthony Anderson’s physician came as a bit of a surprise to him reports My San Antonio. “I thought I was healthy, you know,” the 47-year-old actor, comedian and writer said. “And I was healthy until the doctor said, ‘Nope! You have type 2 diabetes.” Click here for full story.
For those with diabetes, air travel can present a variety of challenges. The Chicago Tribune outlines a few precautions and some creative ways you can reach your destination without experiencing a health crisis. Click here for full story.
One in four patients in outpatient treatment settings suffers from breathlessness. Acute and chronic lung diseases are usually the main causes, reports Science Daily. New studies have found that breathlessness and conditions of restrictive lung disease may be a late complication of Type 2 diabetes. Click here for full story.
Women who work long hours may be at a heightened risk for diabetes, a new study examined by MedPage Today found. Specifically, those who worked ≥45 hours in 1 week reported a significantly higher risk for developing incident diabetes compared with women who worked 35-40 hours each week. Click here for full story.
Smart patches fitted with micro needles to deliver insulin could “revolutionise” treatment for diabetes sufferers, reports BBC News. The 0.7mm hollow needles would be less intrusive than standard needles by only perforating the surface of the skin. The patch would monitor insulin levels and the micro needles deliver the dose. Click here for full story.
Dr. Anne Peters talks about the new ASA/EASD treatment guidelines for managing patients with Type 2 diabetes for Medscape. Although guiding people is difficult, these guidelines actually begin to guide us in the treatment of our patients with type 2 diabetes. Click here for full story.
When someone is diagnosed with diabetes, other family members seem more likely to adopt healthy lifestyle changes, too. As reported by HealthDay. A new study found that partners of people newly diagnosed with diabetes were 50 percent more likely to attend weight management classes and 25 percent more likely to get medication to help quit smoking. Click here for full story.
As reported by CBS News New York, a new generation of continuous glucose monitors (CGM) are so good that many doctors say everyone with diabetes should be using it. The new Dexcom G6 is taking the pain, and unpredictability out of monitoring your diabetes. Click here for full story.
A new study shows the blood pressure drug, verapamil, appears to protect some of the pancreatic cells that are damaged, allowing them to continue producing a little insulin. As outlined by NBC News, this cheap blood sugar drug might slow the worsening of Type 1 diabetes. Click here for full story.
A new study, designed to estimate the harmful effects of poor air quality, revealed a significant correlation between diabetes and pollution levels. Medical News Today outlines this strong link between air pollution and diabetes. Click here for full story.
Vegan and vegetarian diets help lower HbA1c and cholesterol levels and improve other cardiometabolic risk factors in middle-aged, overweight people controlling their type 2 diabetes with medications according to a study highlighted by Medscape. This level of reduction suggests that patients could consider moving toward a plant-based diet that is primarily vegetables, fruits, whole grains, and legumes, perhaps even before they move to diabetes medications. Click here for full story.
Currently, individuals with Type 1 diabetes must inject themselves with the required dose of insulin daily to manage their condition. As reported by Medical News Today, scientists are developing a viable way of delivering insulin in pill form, in hopes of making injections no longer necessary. Click here for full story.
Spending on diabetes drugs in the United States broke $50 billion last year, more than double what it was in 2013. CNBC reports that the Geisinger Health Systems in Pennsylvania is testing a new program called Fresh Food Farmacy which includes education and free nutritious meals that can lower diabetes treatment costs by 80 percent. Click here for full story.
According to Everyday Health, a Type 2 diabetes diagnosis after age 50 is a known risk factor for pancreatic cancer, and in Latino and African-American people with diabetes who are diagnosed with pancreatic cancer within three years, pancreatic cancer itself may manifest as diabetes. The findings may help doctors identify more people at risk for the potentially deadly cancer. Click here for full story.
A new study by researchers from the University of Illinois at Chicago found that Daily fasting is an effective tool to reduce weight and lower blood pressure. The study outlined by Science Daily found that those who fasted 16 hours a day consumed about 350 fewer calories, lost about 3 percent of their body weight and saw their systolic blood pressure decreased by about 7 mm Hg in a 12-week trial. Click here for full story.
The University of Guelph found that replacing potatoes or rice with pulses can lower your blood glucose levels by more than 20 percent in a new study. The study found that swapping out half of a portion of these starchy side dishes for lentils can significantly improve your body’s response to the carbohydrates. Click here for full story.
New results from a large-scale study suggest that the oral diabetes drug metformin is safe for most diabetics who also have chronic kidney disease. As reported by Science Daily, investigators found that metformin’s association with the development of a life-threatening condition called lactic acidosis was seen only among patients with severely decreased kidney function. Click here for full story.
Research suggests that sleeping in a light room may cause Type 2 diabetes. The study, outlined by Daily Mail found that after spending just one night in a faintly-lit room, people had greater levels of insulin resistance. Click here for full story.
A new study conducted by the Johns Hopkins Bloomberg School of Public Health in Baltimore suggests that one blood test might be enough to diagnose Type 2 diabetes. CBS News reported that this new research could save patients time and health care costs. Click here for full story.
A new study evaluated the quality of life and metabolic control in patients with diabetes based on the effects of mindfulness-based interventions. The Medical News Bulletin cite the acceptance and commitment therapy as being noteworthy. Click here for full story.
According to analyst Robbie Marcus, “the diabetes space is currently experiencing its biggest technological wave of innovation.” As reported by CNBC, JP Morgan views the changes to glucose monitoring as a significant upside to the market. Click here for full story.
Science Daily reports that a team at the University of Exeter Medical School found new research that shows the rapid decline in insulin production that is known to cause Type 1 diabetes continues to fall over seven years, and then begins to stabilize. Click here for full story.
Alcohol can both increase and decrease the levels of blood sugars, exacerbating pre-existing diabetic symptoms. News Medical Life Sciences, outlined the connections between alcohol and diabetes. Click here for full story.
Data from a new report outlined on Medical News Today suggests that high salt consumption may be killing certain gut bacteria. This “good” gut bacteria could contribute to high blood pressure and disease affecting the immune system. Click here for full story.
A new study evaluated the quality of life and metabolic control in patients with diabetes based on the effects of mindfulness-based interventions. The Medical News Bulletin cite the acceptance and commitment therapy as being noteworthy. Click here for full story.
A new large-scale study confirms the widely-accepted idea that nonnutritive sweeteners do not raise blood sugar. As outlined by U.S. News & World Report, the study concluded that artificial sweeteners alone won’t cause a spike in blood sugar. Click here for full story.
According to a retrospective cohort study detailed by Endocrinology Advisor, the long-term use of metformin is associated with decreased risk of men with diabetes getting colorectal cancer. Click here for full story.
A research study conducted by a team from Sapienza University that could pave the way to new perspectives for the treatment of diabetes. Research Italy reports that there is a component in Extra-Virgin Olive Oil that could reduce post-prandial blood sugar levels. Click here for full story.
This Sunday, June 10th is the American Diabetes Association’s Tour de Cure. Director of the American Diabetes Association, Laura Greenaway joined CBS 6 News to discuss the events. Click here for full story.
Healthline investigated a recent study to see if a month and a half of intense exercise can actually improve the health of someone with diabetes. The study published in Experimental Physiology looked at an intensive CrossFit program and the effects it has on people with Type 2 diabetes. Click here for full story.
Medpage Today outlined a study of participants in an employee wellness program. The study concluded that some people still might be a higher risk for diabetes even with normal fasting glucose results as identified by a glycated hemoglobin (HbA1c) test. Click here for full story.
A new study suggests that Canadians with cannot afford to regularly eat, or eat a healthy diet, have more than double the average risk of developing Type 2 diabetes. As reported by Reuters, the study team believes policymakers and the national healthcare system should consider intervening by reducing food insecurity. Click here for full story.
According to researchers at The University of Texas Health Science Center at Houston, there is a link between the consumption of milk and the risk of diabetes in obese children. Science Daily states that obese children who consume at least two servings of cow’s milk daily are more likely to have lower fasting insulin, which indicates better blood sugar control. Click here for full story.
In this article, Helio talks about the role of nutrition in prevention and treatment of diabetic foot ulcers. Nutrition critical in healing diabetic foot ulcers, and Diabetes educators should include nutrition assessment and intervention as key components of the overall diabetes treatment plan to help patients with diabetic foot ulcers. Click here for full story.
Fay Robson is a blogger living with, and managing Type 1 diabetes for Metro. In her 25 years living with diabetes, things have certainly gotten easier, but in this article, she outlines some of the ways that her diabetes leave her feeling isolated from having fun with family and friends. Click here for full story.
Diabetes is a metabolic disorder, and once it develops, complications may be prevented or mitigated by medical treatment, controlling body weight, ensuring regular physical activity, and more. In this article from News Medical, steps are outlined for what you can do to help control your diabetes during a diabetic emergency. Click here for full story.
Despite a lack of evidence to back up claims, fasting diets have been viewed as a solution for weight loss and good health in recent years. Newsweek reported that a team of scientists based out of Brazil has warned these fasting diets can increase the risk of developing diabetes. Click here for full story.
Reuters reports a new study out of the U.S. suggests that doctors are often slow to switch patients to more intensive treatments when their oral medications are not controlling their Type 2 diabetes. Click here for full story.
In the past four years, the number of children diagnosed with Type 2 diabetes has jumped by an astounding 25%. As reported by MSN Lifestyle, Tam Fry of the National Obesity Forum said this rise occurred because countries failed to stop obesity in the early years. Click here for full story.
A new study outlined in EurekAlert reports that pain hypersensitivity in patients with diabetes might be the result of disrupted insulin signaling in pain sensory neurons, contradictory to past assumptions that it is from damage to blood vessels or local tissue surrounding neurons caused by high blood-sugar levels. Click here for full story.
New reports from a retrospective cohort study suggest that obese adults who lower their weight to a non-obese body-mass index before hitting middle age reduced their risk for diabetes. As reported by MedPage Today, those in the study lowered their risk by nearly 70% compared to those who were obese as young adults and stayed that way into middle age. Click here for full story.
Researchers from the UC San Diego Jacobs School of Engineering have designed a needleless “tattoo” sensor to measure blood sugar levels in sweat. Applied similarly to a temporary tattoo, as mentioned by Healthline, you just apply it to the arm with a little water, and remove the backing. Click here for full story.
According to Reuters, both the American Diabetes Association and the American Psychological Association have worked together to create a new public health directory of mental health providers with diabetes-specific education or experience. Click here for full story.
A new study, outlined on AAP News, showed that a community of children and adults with Type 1 diabetes mellitus who adhered to a very low-carbohydrate diet saw exceptional glycemic control with low rates of adverse events. Click here for full story.
A study of female breast cancer patients examined those treated with either tamoxifen or an aromatase inhibitor. MedPage Today reports that it made patients significantly more likely to develop diabetes during a median follow-up of 5.9 years compared to those who did not have hormonal therapy. Click here for full story.
In this New York Times article, we meet Andrew, a 13-year-old with Type 1 diabetes. When he was young, his parents switched him to a low-carbohydrate, high-protein diet in order to control his blood sugar levels. Click here for full story. 
Contrary to popular belief, a new study conducted by University of Sydney researchers finds that egg consumption and increase cardiovascular risk may not be related. The study detailed on Science Daily, found that eating up to 12 eggs per week did not increase cardiovascular risk factors in those with pre-diabetes and Type 2 diabetes. Click here for full story.
According to findings outlined by Healio, children with Type 1 diabetes that displayed greater variability in their sleep duration between weekdays and weekends were more likely to check their blood glucose less frequently, have higher HbA1c levels and spend less time targeting blood glucose range versus children that maintain a regular bedtime. Click here for full story.
Researchers suggest that people with Type 1 diabetes who follow a very low-carbohydrate diet have a greater chance of achieving glycemic control. As discussed on MedPage Today, the results of an online survey showed that 97% of participants that followed a VLCD achieved the recommended glycemic targets of the American Diabetes Association. Click here for full story.
Source URL: https://www.diabetesselfmanagement.com/blog/this-week-in-diabetes-news/
Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.
Copyright ©2021 Diabetes Self-Management unless otherwise noted.